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Abstract 
Aortic valve disease is currently the leading cause of cardiovascular 
morbidity in the United States.1 In 2003, approximately 290,000 patients required 
heart valve replacement and that number is estimated to continue to rise as the 
average age of the population continues to increase.2 However, the current valve 
replacement options have multiple limitations. Tissue engineering hopes to address 
these shortcomings by providing a viable valve that more closely mimics the native 
valve, structurally and functionally.3 An ideal valve replacement should contain 
endothelial and interstitial cells, with the ability to remodel the extra-cellular 
matrix. While tissue-engineered heart valves are not uncommon in the field, 
retaining an adequate monolayer of endothelial cells on the scaffold surface remains 
an unresolved challenge. Without a functional endothelial layer, the implant can 
become thrombogenic, initiate an immune response, and become incapable of 
conducting necessary communications with the underlying interstitial cells. The 
focus of this series of studies is to create a seeding method that optimizes the 
adherence and uniformity of endothelial cells on an acellular heart valve scaffold.  
This study has three approaches to maximize endothelial cell adhesion: the 
use of protein substrates, the application of hydrogels, and dynamic seeding. First, 
protein substrates – laminin and fibronectin – were applied to samples of decelled 
bovine pericardium and seeded with endothelial cells in static conditions. In the 
next study, hydrogels – PureCol, Q.Gel, and fibrin glue – were applied to the surfaces 
ii 
of tissue samples followed by the aforementioned protein substrates and finally 
seeded statically with endothelial cells. A novel rotating device was then used to 
dynamically seed the decelled native valve. Finally the seeded valve was analyzed in 
vitro for cellular retention by exposing the valve to physiological shear stress in the 
heart valve bioreactor.  
The use of substrates in combination with fibrin glue has shown to increase 
endothelial cell adhesion on bovine pericardium in proof-of-concept studies. A 
rotating device for valve seeding applications has shown positive results for uniform 
and confluent endothelial cell coverage. These studies will serve as a reference for 
future endothelialization studies as the field of cardiovascular tissue engineering 
strives to develop permanent solutions for patients with valve or vascular diseases.  
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Acknowledgments 
     I would like to thank my advisor, Dr. Agneta Simionescu, and committee 
members, Dr. Dan Simionescu and Dr. Naren Vyavahare. I would also like to thank 
the Biocompatibility and Tissue Regeneration Lab and Cardiovascular Tissue-
Engineering and Regenerative Medicine Lab partners, Dr. Lee Sierad, and Dr. 
Michael Jaeggli for all of their help and support throughout the entirety of my 
research.  I would also like to acknowledge COBRE funding, my peers within the 
Clemson University Bioengineering Graduate School, the Clemson University 
Bioengineering Department, and Snow Creek Meat Processing facility for donating 
the heart valves.
iv 
Table of Contents 
Title Page  ......................................................................................................................................... i 
Abstract .  .........................................................................................................................................ii 
Acknowledgments .......................................................................................................................... iv 
Part 1: Introduction and Background ............................................................................................. 1 
Chapter 1: Anatomy and Physiology of the Heart .......................................................................... 2 
1.1 Components of the cardiovascular system ........................................................... 2 
1.1.1 Tissue layers & the pericardium ............................................................................ 2 
1.1.2 Chambers and valves of the heart......................................................................... 3 
1.1.3 The route of blood flow ......................................................................................... 4 
Chapter 2: The Anatomy and Physiology of the Aortic Valve ........................................................ 6 
2.1 Anatomy of the valve ............................................................................................ 6 
2.2 Biomechanics of the valve ..................................................................................... 7 
Chapter 3:  Aortic Valve Pathology ............................................................................................... 11 
3.1 Calcification ......................................................................................................... 12 
3.2 Current treatment options .................................................................................. 14 
Chapter 4: Valvular Endothelial Cells & their Interactions with ECM .......................................... 16 
4.1 The roles of valvular endothelium ...................................................................... 16 
4.1.1 Coagulation ......................................................................................................... 17 
4.1.2 Maintenance of mechanical properties .............................................................. 17 
4.1.3 Regulation of immune response ......................................................................... 18 
4.1.4 Tissue permeability ............................................................................................. 18 
4.2 The extracellular matrix ...................................................................................... 19 
4.3 Dysfunctional Endothelium ................................................................................. 21 
Chapter 5:  Heart Valve Tissue-Engineering Approach ................................................................ 23 
5.1 The Need for a Long-Term Solution .................................................................... 23 
5.2 The Tissue Engineering Process ........................................................................... 23 
5.3 Review of Current Research in Endothelialization Methods............................... 25 
v 
Page
5.3.1 Decellularization .................................................................................................. 25 
5.3.2 Scaffold Stabilization ........................................................................................... 26 
5.3.3 Cell Seeding ......................................................................................................... 27 
5.3.4 Fluid Flow Devices (Bioreactors) ......................................................................... 28 
5.3.5 Analysis of Endothelial Cells Attachment ............................................................ 28 
Chapter 6:  Project Rationale and Aims ........................................................................................ 32 
Part 2: Research Methods, Results, Discussion and Conclusion .................................................. 33 
Chapter 1:  Materials and Methods ............................................................................................. 34 
1.1 Study 1: Static seeding of TE valve with incremental rotation in seeder 
for analysis of cellular adhesion .......................................................................... 34 
1.1.1 Pericardium Decellularization ............................................................................. 35 
1.1.2 Pericardium PGG Fixation & Neutralization ........................................................ 36 
1.1.3 Mounting the Tissue into a Valve ........................................................................ 36 
1.1.4 Endothelial Seeding of the Engineered Valve ..................................................... 37 
1.1.5 Staining and Imaging with DAPI .......................................................................... 38 
1.1.6 Staining and Imaging with Hematoxylin and Eosin ............................................. 39 
1.2 Study 2: Static seeding of TE valve with incremental rotation and 
exposure to shear stress for analysis of cellular retention ................................. 41 
1.2.1 Making of the Tissue-Engineered Valve .............................................................. 41 
1.2.2 Cell Seeding ......................................................................................................... 41 
1.2.3 In Vitro Testing in the Heart Valve Bioreactor .................................................... 42 
1.3 Study 3: Static seeding of bovine pericardium tissue samples with 
endothelial cells and with added adhesive protein substrates for 
increased cellular adhesion ................................................................................. 44 
1.3.1 Pericardium Sample Preparation ........................................................................ 45 
1.3.2 Coating with Fibronectin and Laminin Solutions................................................. 45 
1.3.3 Block Nonspecific Binding on the Tissue Surface ................................................ 46 
1.3.4 Drop Seeding Tissue Samples with Endothelial Cells .......................................... 46 
1.3.5 Live/Dead Assay .................................................................................................. 47 
1.3.6 Immunohistochemistry for Analysis of Laminin Presence .................................. 48 
1.4 Study 4: Static seeding of bovine pericardium tissue samples with 
endothelial cells treated with fibronectin and laminin protein substrates 
vi 
PageTable of Contents (Continued)
and PureCol, Q.Gel, and Fibrin Glue hydrogels for increased cellular 
adhesion .............................................................................................................. 50 
1.4.1 Sample Preparation and Experimental Design .................................................... 50 
1.4.2 Scaffold Modification with Fibrin Glue ................................................................ 51 
1.4.3 Scaffold Modification with PureCol ..................................................................... 52 
1.4.4 Scaffold Modification with Q.Gel ........................................................................ 52 
1.4.5 Scaffold Modification with Substrates and Cell Seeding ..................................... 53 
1.4.6 Cellular Adhesion, Coverage, and Viability Analysis ............................................ 53 
1.5 Study 5: Application of fibrin glue hydrogel and protein substrate surface 
modifications on decelled and harvested porcine native valves, dynamic 
seeding, and cellular adhesion and uniform coverage analysis .......................... 54 
1.5.1 Aortic Valve Harvesting and Decellularization by Immersion ............................. 55 
1.5.2 Harvested Valve PGG Fixation and Neutralization .............................................. 57 
1.5.3 Harvested Valve Surface Modification with Fibrin Glue and Substrates ............ 57 
1.5.4 Endothelial Cell Seeding of Harvested Valve in Dynamic Seeder ........................ 59 
1.5.5 Cellular Adhesion, Coverage, and Viability Analysis ............................................ 63 
1.5.6 Statistical Analysis of Fibronectin and Laminin Treatments Using ImageJ ......... 64 
1.5.7 Scanning Electron Microscopy Sample Preparation and Imaging ....................... 64 
1.6 Study 6: Application of fibrin glue hydrogel and laminin substrate 
solution surface modifications on decelled and harvested porcine native 
valves, dynamic seeding, and in vitro testing for cellular retention 
analysis ................................................................................................................ 65 
1.6.1 Valve Preparation, Surface Modification, and Endothelial Seeding ................... 66 
1.6.2 In Vitro Testing in the Heart Valve Bioreactor .................................................... 66 
1.6.3 Cellular Adhesion, Coverage, and Viability Analysis ............................................ 67 
Chapter 2: Experimental Results and Discussion ......................................................................... 68 
2.1 Study 1:   Static seeding of TE valve with incremental rotation in seeder 
for analysis of cellular adhesion .......................................................................... 68 
2.2 Study 2: Static seeding of TE valve with incremental rotation and 
exposure to shear stress for analysis of cellular retention ................................. 70 
2.3 Study 3: Static seeding of bovine pericardium tissue samples with 
endothelial cells and with added adhesive protein substrates for 
increased cellular adhesion ................................................................................. 71 
vii 
PageTable of Contents (Continued)
2.4 Study 4: Static seeding of bovine pericardium tissue samples with 
endothelial cells treated with fibronectin and laminin protein substrates 
and PureCol, Q.Gel, and Fibrin Glue hydrogels for increased cellular 
adhesion .............................................................................................................. 75 
2.5 Study 5: Application of fibrin glue hydrogel and protein substrate surface 
modifications on decelled and harvested porcine native valves, dynamic 
seeding, and cellular adhesion and uniform coverage analysis .......................... 80 
2.6 Study 6: Application of fibrin glue hydrogel and laminin substrate 
solution surface modifications on decelled and harvested porcine native 
valves, dynamic seeding, and in vitro testing for cellular retention 
analysis ................................................................................................................ 87 
Chapter 3: Conclusions ................................................................................................................. 90 
3.1 Study 1: Static seeding of TE valve with HADSCS and incremental rotation 
for analysis of cellular adhesion .......................................................................... 90 
3.2 Study 2: Static seeding of TE valve with HADSCS and incremental rotation 
followed by exposure to shear stress for analysis of cellular retention ............. 90 
3.3 Study 3: Static seeding of pericardium samples with HCAECS and treated 
with adhesive protein substrates for increased cellular adhesion ..................... 90 
3.4 Study 4: Static seeding of tissue samples with HCAECS and treated with 
protein substrates and hydrogels for increased cellular adhesion ..................... 91 
3.5 Study 5: Dynamic seeding of native valve with HCAECS and treated with 
protein substrates and fibrin glue for cellular adhesion analysis ....................... 91 
3.6 Study 6: Dynamic seeding of native valve with HAECS and treated with 
laminin and fibrin glue followed by in vitro testing for cellular retention 
analysis ................................................................................................................ 91 
Future Work ................................................................................................................................. 93 
References: ................................................................................................................................... 94 
viii 
PageTable of Contents (Continued)
Table of Figures 
Figure 1: Coronal section of the heart showing the atria, ventricles, valves, and the flow 
of blood through the heart1 ............................................................................................................ 3 
Figure 2: Superior view of the fibrous skeleton of the heart showing all four valves. The 
mitral and tricuspid valves are opened while the pulmonary and aortic valves are in the 
closed position.4 .............................................................................................................................. 4 
Figure 3: Detailing the route of blood flow in the heart and throughout the body.  The 
right ventricle forces deoxygenated blood (in blue) into the lungs for gas exchange. The 
right ventricle pushes blood through the aorta and to the rest of the body.4 ............................... 5 
Figure 4: The three layers of a native cusp - Fibrosa, spongiosa, and ventricularis. 
Endothelial cells can be seen on the fibrosa and ventriucularis while interstitial cells are 
found in the spongiosa.3 .................................................................................................................. 7 
Figure 5:  Decellularized explanted porcine aortic valve oriented with the outflow side 
up. The arrows are demonstrating the location of the sinuses, the cavity behind each of 
the leaflets that extrudes from the aortic root. .............................................................................. 8 
Figure 6: Decellularized explanted porcine aortic valve that has been cut along the aortic 
root and opened up to view the 3 cusps, or leaflets. The sinuses are the regions behind 
each of the cusps. ............................................................................................................................ 9 
Figure 7: Eddy currents are created in the sinuses when blood flows through the valve 
which aid in the closing of the valve. When the valve is closed, pressure increases on the 
inflow side of the valve which pushes the valve back open.11 ...................................................... 10 
Figure 8: Stenotic aortic heart valve during systole is shown in figure B and compared to 
a healthy valve in figure A.13 .......................................................................................................... 12 
Figure 9: Regurgitant aortic valve during diastole shown in figure B compared with a 
health valve during diastole shown in figure A.13.......................................................................... 12 
Figure 10: Increased nonspecific permeability of the endothelial cells from abnormal 
shear stress, allowing macrophages to invade the interior of the leaflet tissue.17 ....................... 14 
Figure 11: Scanning electron microscope image of a native endothelium of porcine 
aortic valve cusp. Courtesy of Lee Sierad. ..................................................................................... 16 
Figure 12: Adhesive proteins fibronectin and laminin create bridges between the ECM 
and neighboring cells by attaching the collagen in the ECM to the cell surface integrins............ 20 
Figure 13: Tissue-engineering paradigm34 ..................................................................................... 24 
Figure 14: Left hand image shows a valve cusp decellularized with trypsin and has intact 
collagen organization but still shows some cells35 while the right handed imaged was 
decelled with detergents and shows no cells but has a porous structure37 ................................. 26 
Figure 15: Immunohistochemistry for collagen type IV on native cusp (A) and re-
endothelialized decellularized porcine valve cusp(B)41 ................................................................. 30 
ix 
Figure 16: Hematoxylin and eosin stain showing the development of tissue layers and 
endothelial cells after 6 weeks of culture43 ................................................................................... 30 
Figure 18: Scanning electron microscopy image of decellularized bovine pericardium 
reseeded with endothelial cells are implanted in vivo. Collagen fibers are intertwined 
with the cells and the morphology show spherical cells and not cell spreading.37 ...................... 31 
Figure 19: 3D printed cusp mold shown on the left and the pericardium cusp after it had 
been cut out of the crush mount .................................................................................................. 37 
Figure 20: Tissue engineered aortic valve from decellularized and PGG fixed bovine 
pericardium and sutured into novel mount .................................................................................. 37 
Figure 21: Valve endothelialization method in chamber and incrementally rotating 
chamber position ........................................................................................................................... 38 
Figure 22: Study 2 endothelial cell seeding diagram ..................................................................... 42 
Figure 23: Heart valve bioreactor filled with culture media and focused on the valve 
mounted in the aortic chamber on the left and showing the entire system on the right. ........... 43 
Figure 24: Heart valve bioreactor can create physiological flow by creating bursts of air 
that force a membrane up which in turn pushed culture media through the valve .................... 44 
Figure 25: Heart valve bioreactor system composed of air chamber (1), media reservoirs 
(2,3) air filter (4), one-way check valves (5,6), pressure transducers (7) and a webcam 
(8). .. 44 
Figure 26: Six-well-plate layout of study where "L" marks the laminin samples, "FN" 
marks the fibronectin samples, and "FBS" marks the control samples ........................................ 46 
Figure 27: Experimental layout of combination of the 3 gels, 2 substrate solutions, and 
controls in a 24 well plate. ............................................................................................................ 51 
Figure 28: Q.Gel provides an environment that closely mimics the native environment 
for cells by providing physical and soluble signals.45..................................................................... 53 
Figure 29: The image on the left highlights the area of the aortic valve that was 
harvested. The middle image is the harvested valve showing the “skirt” at the bottom 
and aortic root at the top. The image on the right is the view from the ventricular side 
showing the “skirt”. ....................................................................................................................... 55 
Figure 30: Harvested aortic valve mounted in rings, coronary arteries sutured, and 
silicone membrane sutured to seal off the aortic side of the valve. ............................................. 59 
Figure 31: Seeding chamber with ring mounted valve inside and the 3D printed lid 
attached and claves (blue) attached for media exchange. ........................................................... 60 
Figure 32: View from the bottom of the seeder of the sealed off valve filled with cell 
solution. ......................................................................................................................................... 60 
Figure 33: Rotator system consists of the metal frame where the seeding chambers can 
be secured and is connected to a stepper motor that is controlled by LabView. The 
system resides in the 37C incubator for cell viability. ................................................................... 62 
x 
PageTable of Figures (Continued)
Figure 34: The metal frame of the rotator is secured to a shake plate. There are 2 
different attachments for the chambers to connet in to depending on the desired 
rotation orientation (axially or end-over-end).  Both attachements are shown. ......................... 63 
Figure 35: Anatech USA Hummer 6.2 Sputter Coater ................................................................... 65 
Figure 36: Nuclear distribution on the inflow (left) and outflow (right) surfaces of TE 
valve statically seeded and stained with DAPI. Taken at 10x (top) and 2.5x (bottom). ................ 69 
Figure 37: H&E stain showing seeded HADSCs on the surface of TE valve cusp cross 
sections taken from the center of the leaflet (A), one-third of the way through the 
leaflet (B), and the outer edge of the leaflet (C). .......................................................................... 69 
Figure 38: Nuclei distribution on the surface of inflow (left) and outflow (right) sides of a 
cusp taken from seeded TE valve after in vitro testing and stained with DAPI. Taken at 
2.5x. 71 
Figure 39: Calcein AM stained pericardium scaffolds treated with laminin (A), fibronectin 
(B), and FBS for control (C) showing endothelial cell distribution and spreading out on 
the surface. Top row imaged at 2.5x and the bottom row at 10x. ............................................... 73 
Figure 40: Cell distribution on cross sections of pericardium scaffolds treated with 
laminin (A), fibronectin (B), and control sample incubated in FBS (C) and seeded with 
endothelial cells and taken at 10x. ................................................................................................ 73 
Figure 41: staining with anti-laminin showing the presence of laminin in cross sections of 
scaffolds treated with laminin and FBS for control.  (A) FBS negative control, (B) FBS 
sample tagged with anti-laminin, (C) laminin sample negative control, and (D) laminin. ............ 74 
Figure 42: IHC staining with anti-laminin on laminin incubated and seeded scaffolds 
imaged at 20x. Both images show cross sections tagged with the antibody. ............................... 75 
Figure 43: Calcein AM stained seeded scaffolds treated with a combination of hydrogels 
and protein substrates showing cellular attachment and spreading after incubating for 3 
days. Taken at 2.5x. ....................................................................................................................... 77 
Figure 44: 24 well plate with the seeded scaffolds in culture media at day 7 of incubation 
(3 day samples have already been removed). ............................................................................... 77 
Figure 45: Calcein AM stained seeded scaffolds treated with a combination of hydrogels 
and protein substrates showing cellular attachment and spreading after incubating for 7 
days. Taken at 10x. ........................................................................................................................ 78 
Figure 46: Cross sections of paraffin embedded cusps taken from porcine valve surface 
modified with hydrogels and protein substrates and seeded with endothelial cells 
stained with H&E after 3 day incubation. Taken at 10x. ............................................................... 79 
Figure 47: Cross sections of paraffin embedded cusps taken from porcine valve surface 
modified with hydrogels and protein substrates and seeded with endothelial cells 
stained with H&E after 7 day incubation. Taken at 10x. ............................................................... 80 
xi 
PageTable of Figures (Continued)
Figure 48: Cross sections of a cusps stained with DAPI taken from:  (A) seeded valve 
treated with fibronectin, (B) seeded valve treated with laminin, (C) native porcine valve, 
(D) decellularized porcine valve. Taken at 10x. ............................................................................. 83 
Figure 49: Surfaces of cusps taken from seeded valves treated with fibronectin outflow 
side (A) and inflow side (B) and treated with laminin outflow side (C) and inflow side (D). ........ 84 
Figure 50: Surface morphology of outflow surface of cusps taken from endothelialzed 
valves modified with laminin (left) and fibronectin (right) imaged with SEM. ............................. 84 
Figure 51: Decelled valve, native valve, and endothelial seeded valves treated with 
fibronectin and laminin were stained for endoethial cell markers CD31, VE-cadherin, and 
vWF using IHC. Images taken at 10x.............................................................................................. 85 
Figure 52: Calcein AM stain showing living cells on the surface of a cusp taken from a 
valve treated with fibrin glue and protein substrates, laminin (A,B) and fibronectin (C, D), 
and seeded with endothelial cells. A, C show the inflow side and B, D show the outflow 
side. Taken at 10x. ......................................................................................................................... 86 
Figure 53: 3D image of calcein AM stain of cusp treated with fibrin glue and adhesive 
substrates laminin (A) and fibronectin (B) taken on a stereomicroscope with green 
fluorescent filter. ........................................................................................................................... 86 
Figure 54: Analytics conducted with ImageJ on 272 total DAPI images of the inflow and 
outflow cusp surfaces from 2 valves treated with fibronectin (FN) and 2 valves treated 
with laminin (LM) .......................................................................................................................... 87 
Figure 55: DAPI stain showing the presence of nuclei on valve cusps after surface 
modifications with fibrin glue and laminin, seeded with endothelial cells, and exposed to 
physiological shear stress in the bioreactor. Left images are from the outflow side and 
right images are from the inflow side. .......................................................................................... 89 
Figure 56: Porcine valve seeded treated with fibrin glue and laminin and seeded with 
endothelial cells after removal from the bioreactor. One of the coronary sinuses and 
cusps has accumulated a thickened portion of fibrin glue. .......................................................... 89 
xii 
PageTable of Figures (Continued)
Part 1: Introduction and Background 
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Chapter 1: Anatomy and Physiology of the Heart 
2.1 Components of the cardiovascular system 
     The heart is a part of the cardiovascular system and in charge of controlling the 
flow of blood throughout the body. Veins collect deoxygenated blood from the 
organs and tissues and carry it to the heart. The heart pumps the gathered 
deoxygenated blood to the lungs where the blood is oxygenated, and then pumps 
the oxygenated blood back to the organs and tissues. This hard-working system 
pumps about 7,000 liters of blood through the heart every day.4 
2.1.1 Tissue layers & the pericardium 
     The wall of the heart itself is divided into 3 tissue layers: the epicardium 
(outermost layer), myocardium (middle layer), and the endocardium (innermost 
layer). The epicardium consists of connective tissue covered by endothelium, blood 
capillaries, and nerve fibers. It serves to reduce friction between the exterior of the 
heart wall and the outside covering described below. The myocardium controls the 
muscular contractions of the heart and is made of cardiac muscle tissue, connective 
tissue, blood capillaries, lymph capillaries, and nerve fibers. The endocardium lines 
all of the heart chambers and covers the heart valves described below. It is made of 
connective tissue, specialized muscle fibers, endothelium, and blood vessels.4 
      The entire heart is then wrapped in a complex covering called the pericardium. 
The pericardium is also comprised of three layers: a double layered serous 
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membrane and an outer fibrous sac. The innermost layer of the serous membrane 
directly touches the epicardium and is termed the visceral (meaning organ) 
pericardium. The middle layer, called the parietal pericardium, is formed from the 
folding of the visceral pericardium on top of itself. Finally, the outermost layer is a 
thick fibrous layer made of dense connective tissue called the fibrous   
pericardium.4, 5
2.1.2 Chambers and valves of the heart 
     The heart is divided into four chambers: the left atrium, the right atrium, the left 
ventricle, and the right ventricle. The atria are superior to the ventricles. The atria 
collect blood when delivered to the heart from the vena cava or the lungs and the 
ventricles contract to force blood out of the heart and into circulation. The chambers 
are shown in Figure 1 below.  
Figure 1: Coronal section of the heart showing the atria, ventricles, valves, and the flow of blood through the heart1 
     There are also four valves in the heart. The valve between the right ventricle and 
atrium is the called the tricuspid valve and the valve between the left ventricle and 
atrium is called the mitral valve (also known as the bicuspid valve). Generically 
3 
these valves are termed the atrioventricular valves and they control the flow of 
blood between the chambers. Additionally, there are valves that control the 
movement of blood out of the heart. The valve between the right atria and the 
pulmonary vessel is called the pulmonary valve and the valve between the left atria 
and the aorta is called the aortic valve.4, 6 All four of the valves can be seen in the 
transverse cross section show in Figure 2 below.  
Figure 2: Superior view of the fibrous skeleton of the heart showing all four valves. The mitral 
and tricuspid valves are opened while the pulmonary and aortic valves are in the closed 
position.4  
2.1.3 The route of blood flow 
     To fully understand the role of the chambers and valves described above, the 
route of blood flow should be traced. First, deoxygenated blood is carried through 
the veins and delivered to the right atrium. When the right atrium contracts (atrial 
systole and ventricular diastole), it forces blood out of the atrium, through the 
tricuspid valve, and into the right ventricle. From the right ventricle, the blood 
proceeds through the pulmonary valve and into the pulmonary arteries. The 
pulmonary arteries lead into the lungs where gas exchange occurs. The oxygenated 
4 
blood leaves the lungs through the pulmonary veins and is delivered to the left atria 
of the heart. The blood flows from the left atria through the mitral valve into the left 
ventricle.  The left ventricle then contracts (ventricular systole and atrial diastole) 
and blood is pushed out of the left ventricle and through the aorta in a large bolus. 
The aorta branches into smaller arteries which carry the oxygenated blood to the 
entire body.4, 7 This process is best described in Figure 3 below.  
Figure 3: Detailing the route of blood flow in the heart and throughout the body.  The right 
ventricle forces deoxygenated blood (in blue) into the lungs for gas exchange. The right 
ventricle pushes blood through the aorta and to the rest of the body.4 
5 
Chapter 2: The Anatomy and Physiology of the Aortic Valve 
3.1 Anatomy of the valve 
     The aortic valve is made of three, equally sized, half-moon shaped cusps (or 
leaflets) a few hundred microns in thickness.  Each cusp is attached to its respective 
sinus which is a physical expansion of the aortic root.8 The aortic valve is located 
between the aorta, the largest artery in the body with a diameter of ~ 3 cm, and the 
left ventricle. It is positioned in the middle of the cardiac base, making it the 
centerpiece of the heart (shown in Figure 2 above). All four valves situated at the 
cardiac base are held in place by what is called the cardiac skeleton. The cardiac 
skeleton consists of rings of connective tissue that surround each of the valves and 
dense connective tissue that extends into the heart, between the ventricles.4 Fibrous 
connective tissue surrounds the aortic valve, providing great support and making it 
the strongest portion of the cardiac skeleton.9   
     The cusp tissue is comprised of three layers:  the fibrosa, the ventricularis, and 
the spongiosa. The fibrosa faces the aortic side of the passageway, the ventricularis 
faces the ventricular side, and the spongiosa is in between these two layers.8  The 
fibrosa is the primary load-bearing surface and consists of densely packed type I 
collagen. The ventricularis is composed mostly of elastin to provide the ability to 
recoil during ventricular diastole. Lastly, the spongiosa provides overall cushioning 
and lubrication between the outer layers and is rich in glycosaminoglycans (GAGs).1 
There are two cell types that reside in this complex scaffold: endothelial cells and 
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interstitial cells. The endothelial cells cover both the outside surfaces, the fibrosa 
and the ventricularis, and serve as a barrier to blood flow as well as control many 
vital functions of the valve.  The interstial cells are found in the center of the tissue 
and are comparable to smooth muscle cells found in the vasculature intima.10 
Together these layers serve to create a very durable and unique composite material. 
Figure 4: The three layers of a native cusp - Fibrosa, spongiosa, and ventricularis. Endothelial 
cells can be seen on the fibrosa and ventriucularis while interstitial cells are found in the 
spongiosa.3 
3.2 Biomechanics of the valve 
     The sinuses function to prevent the valve leaflet from completely touching the 
aortic wall and getting stuck when opened and to help to facilitate valve closure by 
creating vortices inside the sinuses when the leaflets are opened. The actual opening 
and closing of the valve is controlled by the creation of a pressure gradient when 
blood flows into the sinuses. The opening of the valve is triggered when the 
pressure gradient changes when the valve is closed and flow slows down. Pressure 
on the inflow side becomes higher than the pressure on outflow side allowing the 
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leaflets to naturally fall open. When the valve is opened (ventricular systole), the 
leaflets push against the sinuses and allow blood to flow out of the ventricle and 
through the aorta.11  As the myocardium relaxes, the pressure in the ventricle 
(inflow side) drops below the pressure in the aorta (outflow side) causing the valve 
to snap shut (ventricular diastole). When the valve is closed, the leaflets come 
together and meet along a fibrous region a small distance from the free edge of the 
leaflet, called the commissure.9  Additionally, the sinuses function to relieve 
abnormal stresses on the leaflets by facilitating a smooth closure. The sinuses are 
able to close smoothly by creating eddy currents that cause the leaflets to begin 
closing before systole is complete, allowing minimal fluid flow to be required for the 
valves to completely close. These flow patterns are detailed in Figure 7. 
Figure 5:  Decellularized explanted porcine aortic valve oriented with the outflow side up. The 
arrows are demonstrating the location of the sinuses, the cavity behind each of the leaflets 
that extrudes from the aortic root. 
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Figure 6: Decellularized explanted porcine aortic valve that has been cut along the aortic root 
and opened up to view the 3 cusps, or leaflets. The sinuses are the regions behind each of the 
cusps. 
     Substantial back pressure is created on the valve when it is closed creating a 
highly demanding environment for the valve to reside.1  Additionally, the aorta and 
the aortic valve are exposed to extreme mechanical forces which each cardiac cycle 
when the blood is pushed through at a high velocity to ensure it reaches all tissues. 
To give an idea, the peak velocity of the blood through the aortic valve is 1.35 ± 0.35 
m/s.8 The aorta’s viscoelastic properties allow for the expansion and recoil at the 
reception of this high blood stroke volume before the blood is passed into the 
arteries. The aortic valve undergoes similar cyclic stretch in order to maintain 
proper homeostatic flow dynamics in these challenging conditions. The endothelial 
cells help conduct these cyclic stretch and relax mechanisms as described in detail in 
section 4.1. 
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Figure 7: Eddy currents are created in the sinuses when blood flows through the valve which 
aid in the closing of the valve. When the valve is closed, pressure increases on the inflow side 
of the valve which pushes the valve back open.11 
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Chapter 3:  Aortic Valve Pathology 
     With heart disease as the primary cause of disability and death in the Western 
world, it accounts for 40% of all postnatal deaths (about 750,000 people) in the 
United States annually.12 Specifically valvular heart disease, a subset of heart 
disease, is when proper functioning of a valve is compromised. Valvular heart 
disease is generally characterized by regurgitation, stenosis, or sometimes both of a 
heart valve. Stenosis is the failure of a valve to open completely so blood does not 
flow freely (shown in Figure 8). If a valve is reguritant it does not close properly and 
allows retrograde flow, or backflow, of blood back into the left ventricle instead of 
being properly expelled through the aorta. Valve regurgitation is shown in Figure 9. 
The severity and rate of development of valvular disease can range from 
physiologically unimportant to rapidly fatal. The severity, duration, cause, and rate 
of onset can affect secondary changes in the heart, vessels, and other organs.11, 12 
     Valvular disease can be a congenital defect, acquired later in life as a result from 
cardiovascular disease, or a consequence of rheumatic fever. Aortic regurgitation 
can result from disease of the valve cusps or damage to the supporting structures 
without primary changes in the actual valve itself. It can be acute but is usually 
chronic caused by a dilation in the ascending aorta, related to hypertension and 
aging. Stenosis, however, is almost always chronic and due to calcification.12    
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Figure 8: Stenotic aortic heart valve during systole is shown in figure B and compared to a 
healthy valve in figure A.13 
Figure 9: Regurgitant aortic valve during diastole shown in figure B compared with a health 
valve during diastole shown in figure A.13 
4.1 Calcification 
     As discussed earlier, the aortic valve resides in a mechanically challenging 
environment due to the extensive number of cardiac cycles, substantial tissue 
fatigue deformations incurred with each cycle, and high pressure gradients created 
across the closed valve. Calcification can be induced by either mechanical wear and 
tear from the environment, from aging, or a congenitally developed bicuspid aortic 
valve. Morphologically, a calcified heart valve contains heaps of calcified masses 
within the cusps that eventually protrude through the outflow surface of the valve 
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and into the sinuses. As calcium deposits accumulate, the valve opening becomes 
impaired.12  
     Valvular oxidative stress is increased in patients with end stage aortic valve 
stenosis and has been tied to the pathogenesis of aortic valve calcification. Oxidative 
stress induces calcification by leading to increased reactive oxygen species, 
amplified osteogenic signaling, and reduced blood lipids.14, 15  
     Additionally, low shear stresses and disturbed flow on the valve surface have also 
been hypothesized to lead to a myriad of pro-calcific effects including:  endothelial 
cell apoptosis and increased permeability, reduced release of paracrine signaling 
molecules like nitric oxide, increased inflammatory cell recruitment, and the 
diffusion of inflammatory molecules into the tissue. When endothelial permeability 
is compromised, macrophages can infiltrate into the tissue (shown in Figure 10), 
become activated, and express proteinases. These proteinases, such as 
metalloproteinases (MMP2 and MMP4), may lead to osteogenic differentiation of 
myofibroblasts or smooth muscle cells.16 Nitric oxide paracrine signaling of valvular 
endothelial cells to interstitial cells is thought to be the mechanism by which 
valvular endothelial cells activate the valvular interstitial cells.17 Activated 
interstitial cells can then differentiate into myofibroblasts or osteoblasts which lead 
to the production of collagen and calcification.14  
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Figure 10: Increased nonspecific permeability of the endothelial cells from abnormal shear 
stress, allowing macrophages to invade the interior of the leaflet tissue.17 
4.2 Current treatment options 
     If diagnosed with valvular heart disease today, there are two treatment options: a 
mechanical or a bioprosthetic heart valve replacement. The mechanical valve 
replacements are made of artificial materials such as carbon, metal, or polymers. 
These valves offer decent hemodynamic functionality and long-term durability; 
however they are known to induce thrombosis and systemic thromboembolism 
which require the patient to take anti-coagulants, such are warfarin, for the rest of 
his or her life.18 Thrombosis is induced from the disruption of flow and damage to 
blood cells, especially around the hinges of the prosthesis.19 Anti-coagulation 
therapies are generally associated with an increased risk in hemorrhage thus is 
unsuitable for many active lifestyles or expecting mothers. 
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      Bioprosthetic valves are fully or partially created from animal or human tissue. 
These valves are less thrombogenic than the mechanical options due to their more 
natural anatomy to the native valve, thus they usually do not require anti-
coagulation drugs. Current bioprosthetic valves on the market are nonviable and 
fixed with gluteraldehyde to prevent an immune response. However, since there are 
no living cells to repair the tissue from normal wear and tear the valve is subject to 
total structural dysfunction.19 This deterioration can stem from intrinsic or extrinsic 
mineralization (calcification) caused from the host’s immune system, the implant 
design, or the induced shear stresses on the valve. Abnormal value motion is 
another factor that could contribute to the deterioration of the valve.20 Therefore, 
the tissue valves have a shorter lifetime and must be replaced every 10-15 years. In 
a study by Hammermeister, it was found that 15% of the patients given an aortic 
bioprosthetic valve replacements and 36% of the patients given a mitral 
bioprosthetic valve replacement saw structural failure at 11 years post 
implantation.18   
     Of the 285,000 annual valve replacement surgeries, about 40% of these cases 
chose the bioprosthetic valve.20  Both valves face major complications such as 
systemic embolism, significant bleeding, regurgitation, thrombosis, endocarditis, 
reoperation, and even death. The bioprosthetic valves are popular among the older 
population who likely will not face an additional operation in their lifetime. Due to 
the aging population however, there has been an increase in use of the tissue 
valves.20 
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Chapter 4: Valvular Endothelial Cells & their Interactions 
 with ECM 
5.1 The roles of valvular endothelium 
     The study of endothelial cells, especially valvular endothelial cells, is a fairly new 
field of study and much information remains unknown about these cells and their 
functioning.  However, it is known that endothelial cells (EC) play crucial roles in the 
maintenance of blood and tissue homeostasis. This includes coagulation, 
transduction of mechanical and biochemical signals, and tissue permeability.21 
Figure 11 below shows the topology of a healthy native endothelial layer. The 
endothelial cells appear to have a “cobblestone” morphology because they are 
spread out and cover every surface of the tissue’s surface. The following sections 
will describe the specific roles of the endothelium.  
Figure 11: Scanning electron microscope image of a native endothelium of porcine aortic 
valve cusp. Courtesy of Lee Sierad. 
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5.1.1 Coagulation 
      The coagulation cascade is initiated when the endothelium becomes injured. The 
endothelial cells mediate coagulation by secreting tissue factor, which leads to the 
formation of fibrin, when stimulated by inflammatory cytokines and shear stresses. 
Von Willebrand Factor (vWF), expressed by the endothelium, aids in the adhesion of 
platelets and fibrin to the activated surface. Since fibrin formation is increased at 
higher shear rates, it is important the valvular endothelium remains non-activated 
to prevent the formation of thrombus.22 However, it is interesting to note that it has 
been observed that shear stress induced valvular endothelial cells rarely result in 
thrombosis compared to vascular endothelial cells.17  
5.1.2 Maintenance of mechanical properties 
     Endothelial cells aid in the maintenance of vasomotor tone through the secretion 
of vasoactive agents such as nitric oxide (NO).21  NO is a vasodilator that functions 
with the tissue’s underlying smooth muscle cells. Valvular endothelial cells release 
NO when exposed to shear stress in order to control the mechanical properties of 
the tissue. For example, it has been shown that these agents increase the elastic 
modulus of the tissue by a significant amount.23 The specific mechanism lies in the 
current of calcium. The release of vasoactive agents controls the smooth muscle 
cells and myofibroblasts which in turn regulate the flow of calcium into the tissue. 
Additionally, in vitro studies have shown that valve tissue can contract and dilate in 
response to vasoactive agents just like vascular endothelial cells, thus changing the 
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actual dimensions of the leaflets.22 The change in dimensions is thought to aid in the 
alignment of leaflets along their lines of commissure and complete closing.   
5.1.3 Regulation of immune response  
     Endothelial cells play an important role in regulating immunogenicity and 
inflammation of the underlying tissue. A healthy endothelium provides a non-
immunogenic surface by protecting against leukocyte rolling and diapedesis, the 
primary inflammatory response. The endothelium also controls the recruitment of 
circulating inflammatory markers such as cytokines and the release of inflammatory 
markers such as intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion 
molecule-1 (VCAM-1), von Willebrand factor, plasminogen activator inhibitor-1, and 
thrombomodulin.24  Thus, endothelial cells are one of the most immunostimulatory 
cell types in the body.25  
5.1.4 Tissue permeability 
     It is also the endothelium’s responsibility to determine how the underlying tissue 
will respond to certain substances such as coagulation factors, lipids, nutrients, and 
molecular stimulants that circulate in the blood 22.  Intact, healthy endothelium is 
tightly connected by intercellular junctions, including connexins and vascular 
endothelial cadherin, and thus do not allow many macromolecules such as 
lipoproteins and albumin to enter the tissue.26 However, it is worth noting that 
valvular endothelial cells have been shown to have an increased permeability 
compared to vascular endothelial cells with the exception of lipoprotein uptake. It is 
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thought the valve is less permeable to LDL (low density lipoproteins) because it is 
already saturated with LDL compared to vasculature.22  
5.2 The extracellular matrix 
     Endothelial cells line the blood vessels and all blood-contacting surfaces, acting as 
a barrier between circulation and the underlying tissue. First, it is important to note 
that valvular endothelial cells have a slightly different morphology and functional 
role than vascular endothelial cells due to their varying mechanical environments. 
In vivo, valvular endothelial cells are elongated, resembling ellipsoids, with the long 
axis of the cell parallel to underlying tissue’s collagenous circumferential pattern 
and perpendicular to the direction of flow. Alternatively, vascular endothelial cells 
align parallel to the direction of flow. The alignment of both types of endothelial 
cells relies on changes within cytoskeletal actin filaments and the formation of 
stress fibers along the long axis of the cell when exposed to shear stress.22  
     The extracellular matrix (ECM) is an interconnected network of macromolecules 
that provides critical support for the endothelium. It is nature’s biologic scaffold 
material for cells because it is created and excreted by the residing cells and is thus 
in homeostasis with the surrounding microenvironment. The ECM consists of 
structural proteins, specialized proteins, and glycosaminoglycans but its exact 
composition can vary depending on its location.27 Proteoglycans form a gel-like 
“ground substance” where fibrous proteins are embedded. Polysaccharide gels help 
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resist compressive forces and allow for the permeability of necessary molecules. 
Collagen gives the ECM strength and organization and elastin provides resilience. 
     Fibronectin and laminin are adhesive glycoproteins part of the ECM and serve to 
attach cells to the ECM by binding the ECM components (such as collagen) to cell 
surface integrins. Fibronectin exists on the cell surface or in the extracellular space 
and consists of the sequence arginine-glycine-aspartic acid (RGD) that is known to 
serve as the specific binding site for cell surface integrins. Fibronectin is also known 
to have roles in cell growth, migration and differentiation.28 Laminin is a major 
component in basement membranes (BM), aids in BM organization, and has been 
shown to enhance cell attachment and spreading.29 
Figure 12: Adhesive proteins fibronectin and laminin create bridges between the ECM and 
neighboring cells by attaching the collagen in the ECM to the cell surface integrins. 
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      The basement membrane is a specialized type of ECM that provides an 
attachment site for cells to adjacent tissues. The basement membrane consists 
mostly of type IV collagen, laminin, nidogen/entactin, and perlecan and plays an 
important role in cell growth and tissue remodeling. The type IV collagen and 
laminin form individual networks crucial for BM stability, and the nidogen/entactin 
and perlecan bridge the laminin and type IV collagen networks to create the 
basement membrane.30, 31   
     Specifically, valvular endothelial cell ECM is composed of an elastin-myofibroblast 
network on the ventricularis and circumferentially aligned collagenous bundles on 
the fibrosa.22 One way the ECM provides structural and organizational stability for 
endothelial cells by allowing the EC binding to it. EC adhesion to the ECM is essential 
for EC proliferation, migration, morphogenesis, and viability. Additionally, this 
relationship helps to mediate cell-to-cell communications that could control cell 
apoptosis, proliferation, and cell morphology.32 
5.3 Dysfunctional Endothelium 
     A healthy endothelium is important for vital functioning of the underlying tissue 
because of the many aforementioned duties of the endothelium. However, if the 
endothelium becomes dysfunctional it has the ability to induce a host of detrimental 
responses. An activated, or dysfunctional, endothelium can become thrombogenic, 
pro-inflammatory, alter proper interstitial cell functioning, and incapable of tissue 
remodeling.15 Thus, endothelial dysfunction is considered a principal initiator in 
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valvular pathology. Increased oxidative stress is one of the major players in 
activating endothelial cells. Dysfunctional endothelium has increased nonspecific 
permeability and allows the uptake of coagulation factors that stimulate platelet 
adhesion and fibrin synthesis. Activated valvular endothelial cells also have an 
increased expression of adhesion receptors (VCAM-1, ICAM-1, and E-selectin) which 
recruits and allows invasion of monocytes and leukocytes. Invaded monocytes and 
leukocytes 1) differentiate into macrophages and attempt to engulf lipids and 2) 
secrete cytokines that stimulate smooth muscle cell differentiation.33  
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Chapter 5:  Heart Valve Tissue-Engineering Approach 
6.1 The Need for a Long-Term Solution 
     As aforementioned, current heart valve replacement options come with severe 
limitations. Mechanical heart valve replacements induce thrombosis and require 
patients to take a lifetime of anti-coagulation therapy while bioprosethic 
replacements suffer from mechanical degradation and must be replaced after 10 – 
15 years. The ideal heart valve replacement would have the ability to self-repair, 
remodel, and allow for somatic growth. In order for a valve to have these features, it 
must be viable, or contain living cells. Creating a viable heart valve comes with an 
extensive list of objectives. In order to support cell growth, the scaffold must also 
not be cytotoxic or induce a chronic immune response. It should have the ability to 
fight off inflammatory cells to prevent chronic inflammation that can lead to valve 
degradation and calcification. However, if these challenges can be overcome, a 
viable heart valve replacement offering could provide a lifetime solution, increased 
patient life time, decrease cardiovascular related morbidity, and cut healthcare cost 
drastically.  
6.2 The Tissue Engineering Process 
     Tissue-engineering is the process of producing therapeutic or diagnostic tools 
that use living cells or attracts endogenous cells to aid tissue formation or 
regeneration. Tissue-engineering (TE) is believed to be the future of organ and 
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tissue repair due the ability to tailor each aspect of the product’s development to fit 
the needs of the patient. According to the tissue-engineering paradigm, a synthetic 
polymer or biologic material scaffold is chosen and then treated to improve the 
mechanical and/or biocompatibility properties. Either differentiated cells or 
undifferentiated stem cells are then added to the scaffold to create a viable product. 
The construct is placed in vitro environment that is metabolically and mechanically 
supportive to allow cell proliferation and extracellular matrix production. In vitro 
environments are often created by using bioreactors to stimulate the physiological 
conditions where the final product would be implemented.  In vitro testing also 
includes using animal models to evaluate mechanical stability, immune response, 
and cellular interactions of the construct with the native environment. Next, the TE 
product is implanted in vivo in hopes it will recapitulate the normal functioning and 
of the native organ or tissue. 34 The diagram below show the tissue-engineering 
paradigm.  
Figure 13: Tissue-engineering paradigm34 
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     As aforementioned, a healthy endothelium is an imperative part of native tissues; 
therefore, a viable, TE solution would also require a functional monolayer of 
endothelial cells on the scaffold’s surface to prevent immune rejection, mechanical 
degradation, and thrombus formation, as well as to ensure proper overall 
functionality of the tissue.  However achieving a well-attached and complete 
monolayer of endothelial cells has been proven to be challenging in the field. An 
effective method to re-endothelialize acellular tissues has not yet been discovered 
or cited in literature. Without an adequate method for endothelialization, tissue-
engineered constructs will not be successful in vivo. The following section reviews 
endothelialization methods currently being researched found in literature and their 
shortcomings. 
6.3 Review of Current Research in Endothelialization Methods 
6.3.1 Decellularization 
     Much research is being conducted to develop a tissue-engineered aortic valve by 
using decellularized xenogeneic scaffolds. Often these scaffolds consist of porcine or 
ovine valves or are made from bovine pericardium. Depending on the scaffold of 
choice and the endothelialization method, a method is chosen to remove all native 
cells and agents that could illicit an immune response after implantation. One 
decellularization method is to conduct a series of Trypsin/EDTA washes. In a study 
conducted by Cebotari et al, human aortic valves were taken from cadavers and 
decellularized with this method. The study reported removal of all cells and 98% of 
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the host DNA from the valve tissue while maintaining the fibrillar structure and 
collagen organization.35 However, when the xenogeneic valve was tested in pigs in 
vivo, aneurysmal dilatation and elastin degradation of the matrix occurred which 
then elicited an immune response in the extracellular matrix. Another detergent 
decellularization method has been utilized in several studies, where a series of 
detergents, such as Trion and/or sodium deoxycholate, is used and followed by 
washes in enzymatic washes DNase and RNase to remove any remaining nuclear 
components. One study reported a cell-free structure across the thickness of the 
leaflet with native wavelike collagen formations intact. However, the tissue was 
loosened with widened interfibrillar spaces creating pores in the scaffold.36 It is also 
reported that this method completely removes all cells and cellular remnants. 37 
Figure 14: Left hand image shows a valve cusp decellularized with trypsin and has intact 
collagen organization but still shows some cells35 while the right handed imaged was decelled 
with detergents and shows no cells but has a porous structure37 
6.3.2 Scaffold Stabilization 
     Enzymes, detergents, spit freezing, and radiation used in decellularization 
techniques can impact the tissue preservation and the valve efficiency.38  If the 
scaffold is deteriorated during the decell process, the scaffold is sometimes 
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stabilized with an agent that cross-links the tissue to enhance the mechanical 
properties after it has been decelled. Non-cross linked scaffolds may degrade too 
quickly and further threaten the functionality of the valve.38 Cross-linking agents 
found it literature can consist of small concentrations of formaldehyde, dialdehyde 
starch, epoxy compounds, gluteraldehyde, or polyphenolic tannins.39, 40 While 
aldehydes are resistant to collagenase degradation they are also cytotoxic and are 
resistant to cell infiltration so this method is not very common if the intent is to seed 
cells.38, 40
6.3.3 Cell Seeding 
     Cells are then seeded on the valve. Often know differentiated endothelial cells are 
used in endothelialization studies.41 In the re-cellularization study by Yang et al, a 
saphenous vein vascular cell suspension was used and allowed to differentiate 
directionally to show the identities of endothelial cells, smooth muscle cells, and 
fibroblasts in vivo.37 Some studies use stem cells that are more readily available but 
then must be differentiated into endothelial cells.42 The density of cells used is can 
vary from study to study. Cebotari et al optimized their concentration to 2x105 per 
square centimeter of tissue35 and Bader et al used 1x105 per square centimeter.36 
While Lichtenberg et al suggested a “suitable number of cells” was 1.2x107 cells per 
square centimeter.41 Sometimes researchers utilize additional biologic materials 
found in the extracellular matrix as cell carriers such as collagen, elastin, hyaluronic 
acid, fibronectin, and fibrin to promote cell adhesion on the scaffold surface since 
the decellularized scaffold is often lacking a basement membrane.38 After the 
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endothelial cells have been added to the valve in suspension, the valve is usually put 
in some type of rotational device or is manually rotated to allow the cells to cover all 
surfaces of the valves.35, 41  
6.3.4 Fluid Flow Devices (Bioreactors) 
     The valves are generally rotated for 12 - 24 hours before placing the seeded valve 
in dynamic conditions. Generally a pulsatile flow loop is created by flowing culture 
medium through the valve at slow rates and then increased over time.35, 41 By 
putting the cells in an environment that mimics the mechanical loading of the 
tissues in vivo, the cells are able to respond how they would in native conditions. 
The objective of these devices is to produce flow through the valve, apply pressure 
and shear stress, and to bend the valve. Two types of dynamic systems are used for 
in vitro tests – simple systems that induce stretching and bending of samples not in 
the shape of a valve and complex systems that induce physiological loading to a 
valve.  Dynamic cultivation of cells has beneficial effects on vascular and valvular 
cells in forming a continuous layer of cells, differentiate cells, and fully mature the 
underlying tissues for improved mechanical properties.38, 43  
6.3.5 Analysis of Endothelial Cells Attachment 
     When the endothelial cells are stimulated with the proper biochemical and 
mechanical signals, they spread out in the aforementioned “cobblestone” 
morphology, lay down a basement membrane, bind to the basement membrane via 
cell surface integrins, and bind to neighboring endothelial cells via cadherins. To 
prove the cells are expressing endothelial cell markers and functioning, the scaffolds 
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are often tagged with anti-bodies for von Willebrand Factor and vascular 
endothelial cadherins using immunohistochemistry or immunofluorescence. 
Hematoxylin and eosin are often used to stain cross sections of the scaffold to 
evaluate if the cells have formed a monolayer on the surface of the scaffold. 
Additionally, scanning electron microscopy images are often taken to view the cell 
morphology.  After it has been determined the endothelial cells are present, well 
attached, and functioning on the scaffold’s surface the valve undergoes in vivo 
testing.  
     However, successfully achieving a complete monolayer of endothelial cells is very 
difficult. Below are results common in literature which attempts to endothelialize 
tissues.   Figure 15 is from a study where the collagen type IV was used to coat a 
decellularized porcine aortic valve and then it was seeded with endothelial cells. 
The figure shows the presence of collagen type IV and some endothelial cells. 
However the study reports that “endothelial cells were detected on the luminal 
surface as an incomplete monolayer.”41 
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Figure 15: Immunohistochemistry for collagen type IV on native cusp (A) and re-
endothelialized decellularized porcine valve cusp(B)41 
     Figure 16 is taken from a study that decellularized porcine aortic heart valves, 
treated the scaffolds with fibronectin and reseeded with marrow stromal cells. The 
figure shows the development of the 3 tissue layers shown in native cusp tissue 
after a 6 week incubation. However, the authors mention “the upper side of the 
leaflet was cellular and compact, whereas the lower ventricular side consisted of 
only loosened acellular matrix without cellular reconstitution.”43  
Figure 16: Hematoxylin and eosin stain showing the development of tissue layers and 
endothelial cells after 6 weeks of culture43 
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  Another study showed scanning electron microscopy images of their bovine 
pericardium valve after 30 days of in vivo implantation in mice. The cells are not 
spread out in the “cobblestone” morphology meaning the endothelial cells are not 
attached to the surface.  
Figure 17: Scanning electron microscopy image of decellularized bovine pericardium 
reseeded with endothelial cells are implanted in vivo. Collagen fibers are intertwined with the 
cells and the morphology show spherical cells and not cell spreading.37  
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Chapter 6:  Project Rationale and Aims 
     Current heart valve replacements can degrade or induce bleeding complications; 
therefore, there is a need for a permanent and effective solution for patients 
requiring heart valve replacements.  As demonstrated in the chapter above, lots of 
tissue-engineering research has been done to create a viable heart valve 
replacement. There are combinations of methods used to decellulararize scaffolds, 
stabilize scaffolds, seed cells, and conduct in vitro testing. However, the ideal heart 
valve solution has not been created yet. The formation of an adequate endothelial 
layer still poses one of the largest problems in tissue-engineered solutions. The 
motivation behind my project is to achieve a layer of healthy endothelial cells for 
heart valve and other vasculature tissue-engineering applications where an 
endothelium is needed.  
Specific aims of my project include:  
• To achieve a confluent and uniform monolayer of endothelial cells on the
scaffold’s surface
• To optimize cellular attachment by the use of protein substrates and
hydrogels
• To optimize cellular conditioning with dynamic seeding
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Part 2: Research Methods, Results, 
Discussion and Conclusion
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1 Chapter 1:  Materials and Methods 
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with laminin and fibrin glue followed by in vitro testing 
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 (page 87) 
1.1 Study 1: Static seeding of TE valve with incremental rotation in seeder 
for analysis of cellular adhesion 
     This study was designed and completed under the direction of Mike Jaeggli, a 
Ph.D candidate in the lab. The purpose of this study was to determine if a uniform 
monolayer of cells could be seeded on the surface of a tissue-engineered (TE) valve 
made of decelled and PGG fixed bovine pericardium.  
34 
1.1.1 Pericardium Decellularization 
     Fresh tissues were received, put on ice, and cleaned of excess fat and loose 
connective tissue. Tissues were placed in double-distilled water (ddH2O) for 24 
hours at 4oC for cell lysis. Tissues were then rinsed with fresh ddH2O and 
transferred to a sterile bottle. All further steps were done with sterile solutions and 
using aseptic techniques. To remove cellular remnants, tissues were treated with 
one liter of a detergent solution consisting of 50 mM tris, 0.15% volume to volume 
ratio of triton x-100, 0.25% deoxycholic acid-sodium salt (DOC), 0.1% EDTA and 
0.02% sodium azide for 3 days at room temperature on a shaker plate. After the 3 
days, the detergent solution was replaced with fresh solution and the tissues were 
treated for an additional 3 days. Tissues were then washed in ddH2O twice for 30 
minutes and 70% ethanol twice for 30 minutes to remove the detergent solution. 
Tissues were then washed twice more with double-distilled water. Removal of 
residual nucleic acids was achieved by treatment for 24 hours at 37OC with 360 
mUnits per mL of both deoxyribonuclease (DNase) and ribonuclease (RNase) 
dissolved in 1x Dulbecco’s phosphate buffered saline (1xDPBS) containing 5 mM 
MgCl at a pH of 7.5. Tissues were washed twice with double-distilled water, 70% 
ethanol, and double-distilled water again. Tissues were stored at 4OC in 1XDPBS 
with 0.02% sodium azide until use. 
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1.1.2 Pericardium PGG Fixation & Neutralization 
      Pentagalloyl glucose (PGG) is an elastin cross-linker that is used to lightly fix 
tissues in order to stabilize the tissue. 0.15% (PGG) solution was made by mixing 
0.75g PGG dissolved in 100 mL of 100% isopropyl alcohol (IPA) and adding 
dropwise to 400 mL of 50 mM Na2hPO4 pH balanced to 5.5. The solution was then 
sterile filtered through a 0.2um filter and the pericardium was placed in the jar with 
the solution and left to incubate on a shake plate at room temperature overnight. 
The PGG solution was kept protected from light the entire time by covering each of 
the solutions in aluminum foil. The next day the PGG solution was aspirated and the 
pericardium was washed three times in 1XDPBS for 30 minutes each wash. The 
tissue was then stored in 0.02% sodium azide until ready to use in order to prevent 
bacterial growth. The day before using the fixed tissue, it was washed 3 times for 10 
minutes in sterile 1x 1XDPBS on the shaker at room temperature and then 
neutralized in 50:50 fetal bovine serum in Dulbecco’s modified Eagle Medium plus 
1% PSA antibiotics (Penicillin-Streptomycin-Amphotericin) overnight at room 
temperature.  
 
1.1.3 Mounting the Tissue into a Valve 
     The sterile, PGG fixed, and neutralized pericardium was cut into three leaflets 
using a mold designed previously in the lab (Figure 13). The leaflets were then 
sutured into one side of a novel 3D printed mount designed by another member in 
the lab, Mike Jaeggli, and then crushed into the other side of the mount to mimic the 
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shape and dimensions of a modern bioprosthetic aortic valve (Figure 14). The 
engineered valve were stored in a sterile jar of 1x 1XDPBS at 4oC.  
Figure 18: 3D printed cusp mold shown on the left and the pericardium cusp after it had been 
cut out of the crush mount 
Figure 19: Tissue engineered aortic valve from decellularized and PGG fixed bovine 
pericardium and sutured into novel mount 
1.1.4  Endothelial Seeding of the Engineered Valve 
     The valve was pre-incubated in culture medium for 24 hours at 37oC. Using a 
specially printed acrylic chamber, the valve was placed in the chamber aortic side 
up and culture media (DMEM: HAM F12, 10% FBS, 1% PSA, 12.5 mL/L of media of 
L-Glutamine) was poured into the chamber until it reached the top of the chamber. 3 
mL of media were removed from the top of the valve. 3 million human adipose 
derived stem cells (HADSCs) suspended in 1 mL of media were added to each of the 
three cusps of the closed valve. The chamber was closed and carefully placed in the 
incubator (aortic side up) at 370C for 6 hours. 3 million more HADSCs were pipetted 
through the lumen of the valve suspended in 3 mL of media and introduced to the 
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ventricular sides of the valve and allowed to sit in a horizontal position so that cusp 
1 was on the bottom side of the chamber in the incubator (position A). After 6 hours 
of incubation, 3 million HADSCs/3 mL were again added through the lumen of the 
valve and the valve was rotated so that the second cusp was allowed to sit on the 
bottom of the chamber (position B). After 6 hours of incubation in position B, 3 
million HADSCs/3mL were again inserted through the lumen and the chamber was 
rotated so the final cusp was allowed to sit on the bottom side of the chamber and 
incubator for 6 hours (position C). A diagram of this procedure is in Figure 15 
below.  
Figure 20: Valve endothelialization method in chamber and incrementally rotating chamber 
position 
1.1.5 Staining and Imaging with DAPI 
     DAPI (4',6-diamidino-2-phenylindole) is a fluorescent stain used to image nuclei. 
Immediately after removing the valve from culture, the cusps were cut out of the 
mount and washed twice in prewarmed 1XDPBS. Two cusps were fixed in 10% 
phosphate buffered formalin and one was fixed in 4% paraformaldehyde (PFA). The 
cusp fixed in PFA was allowed to sit for 10 minutes at room temperature in the 
Position A Position B Position C
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fixative and then washed twice with 1XDPBS. In the meantime 100 ul of 1mg/mL 
DAPI aliquot was added to 19.9 mL of 1XDPBS, vortexed, and covered in foil to 
protect from light. The samples were then allowed to incubate in the DAPI solution 
for 5 minutes at room temperature in the dark. The samples were rinsed twice with 
1XDPBS and left in the 1XDPBS for imaging. The blue fluorescent filter was used to 
image the section.  
1.1.6 Staining and Imaging with Hematoxylin and Eosin 
     Histology allows observation of sample cross sections. The cross sections of 
tissue baked on glass slides can then be stained with a variety of dies to label 
cellular component of interest. A common histology stain is a combination of 
hematoxylin and eosin. Hematoxylin stains nuclei dark purple and eosin stains 
cytoplasm pink.  
     After being in the phosphate buffered formalin for 5 days, the cusps were taken 
out of the fixative, first cut in symmetrical halves, and then cut vertically dividing 
the cups half into thirds. Each section was placed in a processing cassette and run in 
an automatic tissue processor to infiltrate the tissue with paraffin wax (Leica 
Medium, Tm 56 - 58oC) according to the following preset protocol: 
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• 10% buffered formalin (1 min) at 37oC
• 10% buffered formalin (1 min) at 37oC
• 70% ethanol (15 min) at 37oC
• 80% ethanol (15 min) at 37oC
• 95% ethanol (15 min) at 37oC
• 95% ethanol (15 min) at 37oC
• 100% ethanol (15 min) at 37oC
• 100% ethanol (15 min) at 37oC
• Xylene (5 min) at 37oC
• Xylene (10 min) at 37oC
• Paraffin (15 min) at 60oC
• Paraffin (15 min) at 60oC
• Paraffin (15 min) at 60oC
• Paraffin (15 min) at 60oC
     The cassettes were then removed from the processor and stored in a warming 
drawer with a thin layer of melted paraffin to prevent the samples from drying out.  
One week later the sections were removed from the drawer, embedded in blocks of 
hot paraffin, allowed to set on a cold plate set at -7oC and then placed in a small 
bucket of ice water. The cold blocks were sectioned at 5 um using an automatic 
microtome. The thin wax embedded sections were transferred into a shallow Pyrex 
dish of 44oC tap water carefully to prevent the sample from bunching and distorting 
the sample. Glass slides were inserted under the floating sections to retrieve the 
samples. The slides were put in a 60oC oven vertically and allowed to incubate 
overnight in order to melt the excess wax away from the section and leave only the 
tissue sample on the slide.  
     The next day the slides were removed from the oven, placed in a slide rack, and 
stained with fresh hematoxylin and eosin solutions (H&E). An established protocol 
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by the Clemson University Department of Bioengineering was used to deparaffinize 
in xylene, dehydrate in a series of ethanol dilutions, rehydrate in water, stain with 
hematoxylin and eosin, and re-dehydrate in ethanol dilutions and xylenes. The 
sections were taken out of the final xylene incubation and immediately coverslips 
were applied with paramount medium, allowed to dry, and then imaged using a light 
microscope.  
1.2 Study 2: Static seeding of TE valve with incremental rotation and 
exposure to shear stress for analysis of cellular retention 
     This study was also designed and conducted under the guidance of Ph.D 
candidate, Mike Jaeggli as a continuation of previous experiment. Since an adequate 
layer of cells was effectively seeded on the valve’s surface in study 1, the goal of this 
study was to determine if the cells would be retained when applied to shear stress.  
1.2.1 Making of the Tissue-Engineered Valve 
     Bovine pericardium was decelled and fixed with half of the previously used 
concentration of PGG (0.075%) according to study 1 sections 1.1.1 and 1.1.2. The 
tissue was then sutured in the mount and crushed into the shape of a valve as 
described in section 1.1.3.   
1.2.2 Cell Seeding 
     A slightly higher concentration of cells was used compared to study 1 but the 
exact same incremental rotating of the seeding chamber was used as described in 
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section 1.1.4. Additionally a different chamber was used to allow for better 
alignment of the seeding ports over the cusps. The valve fits ventricular side down 
in the new chamber just like in the previous chamber design; however, the new 
chamber has three ports on the top – one over the aortic side of each cusp – and one 
port on the bottom – for ventricular side seeding. These slight seeding changes are 
shown in the Figure 16. After the last seeding rotation in position C, the chamber 
was turned upside down (ventricular side up) and allowed to incubate for 24 hours 
before putting in the bioreactor. 
Figure 21: Study 2 endothelial cell seeding diagram 
1.2.3 In Vitro Testing in the Heart Valve Bioreactor  
     After the valve was removed from the seeding chamber, it was placed in the heart 
valve bioreactor designed by Dr. Lee Sierad, a Ph.D. graduate and post-doctorate of 
the BTRL, and filled with culture media. The bioreactor is used to create 
physiological flow to study scaffolds in vitro by using bursts of air controlled by 
LabVIEW to force a silicone membrane (diaphragm) up and push media through the 
valve. Figure 18 and Figure 19 demonstrate the bioreactor how the membrane is 
used to open and close the valve. Volumetric flow rate, systolic pressure, beats per 
Position A Position C Position B 
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minute, and diastolic pressure can be measured and adjusted and were done so 
according to the table below. After 24 hours in the bioreactor, it was noticed that the 
membrane was pierced and thus not functioning correctly and the valve was 
removed from the bioreactor and placed in 4% PFA and imaged with DAPI 
according to the protocol in study 1 (1.1.5). 
Figure 22: Heart valve bioreactor filled with culture media and focused on the valve mounted 
in the aortic chamber on the left and showing the entire system on the right. 
Beats per minute 21.4 
Stroke volume (mL) 1.43 
Systolic Pressure (mmHg) 12 
Diastolic Pressure (mmHg) 4 
Study 2 valve conditions created by the bioreactor 
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Figure 23: Heart valve bioreactor can create physiological flow by creating bursts of air that 
force a membrane up which in turn pushed culture media through the valve 
Figure 24: Heart valve bioreactor system composed of air chamber (1), media reservoirs (2,3) 
air filter (4), one-way check valves (5,6), pressure transducers (7) and a webcam (8). 
1.3 Study 3: Static seeding of bovine pericardium tissue samples with 
endothelial cells and with added adhesive protein substrates for 
increased cellular adhesion  
     Since inadequate cellular retention was observed after the tissue-engineered 
valve was statically seeded and put in the bioreactor in study 2, the objective of this 
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study was to determine if adhesive protein substrates could be used to increase the 
strength of cellular attachment on the scaffold’s surface. Since endothelial cells have 
unique structural and behavioral characteristics in vivo, this study and the 
subsequent studies were completed with known endothelial cells to effectively 
analyze endothelial cell attachment and functioning.  
1.3.1 Pericardium Sample Preparation 
     Bovine pericardium was decellularized, PGG fixed in 0.075% PGG, and 
neutralized according to the protocols in sections 1.1.1 and 1.1.2. The pericardium 
was then cut into 2.5 cm x 2.5 cm square samples and divided in a 6 well plate.  
1.3.2 Coating with Fibronectin and Laminin Solutions 
     11 ug/mL of fibronectin (1 mg/mL from bovine plasma) in 1XDPBS was sterile 
filtered through a 0.2um filter. 5 ug/mL of laminin (1mg/mL from Engelbreth-Holm-
Swarm mouse sarcolemma) in 1XDPBS was also filtered through a 0.2 um filter. All 
steps from this point forward were conducted under sterile conditions using aseptic 
technique and sterile solutions and tools. 1 mL of the laminin solution, 1 mL of the 
fibronectin solution, and 1 mL of warmed fetal bovine serum (FBS) for control was 
pipetted on the respectively labeled tissue samples. The well plate was sealed with 
Parafilm and the samples incubated in the solutions at room temperature overnight. 
The next day the solutions were aspirated and the samples were washed 3 times 
with sterile 1XDPBS.  
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Figure 25: Six-well-plate layout of study where "L" marks the laminin samples, "FN" marks the 
fibronectin samples, and "FBS" marks the control samples 
1.3.3 Block Nonspecific Binding on the Tissue Surface 
     0.02% bovine serum albumin (BSA) in 1XDPBS was prepared and sterile filtered 
into a conical tube. A beaker of ddH2O was warmed to 45oC on a hot plate and the 
conical was placed in the hot water for 10 minutes. The 1XDPBS was aspirated from 
the wells and 1 mL of the heat-treated BSA was pipetted on the each of the samples 
and allowed to incubate for 2 hours at 37oC. The BSA solution was aspirated and 
tissues were rinsed with 1XDPBS 3 times.  
1.3.4 Drop Seeding Tissue Samples with Endothelial Cells  
     Passage 5 human coronary artery endothelial cells (HCAECs) was trypsinized 
with 10 mL of trypsin-EDTA solution in a 5x dilution with prewarmed, sterile 
1XDPBS for 5 minutes at 37oC (followed cell product protocol). The reaction was 
quenched with 10 mL of endothelial cell growth culture media from ATCC kit 
(Ascorbic acid, FBS, rh EGF, Heparin Sulfate, L-Glutamine, rh VEGF, rh FGF-b, rh IGF-
1, Hydrocortisone in basal media). The flasks were rinsed with sterile 1XDPBS twice 
to remove the residual cells. The cell solution was spun down in a centrifuge at 
200xg for 3 minutes. The supernatant was removed and the pellet was resuspended 
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in 3 mL of new prewarmed culture media. A scepter was used to count the cells and 
2.94 x 103 cells were added to the center of each sample in a small volume of media 
(200uL) to minimize cell runoff. The well plate was placed in the 37oC incubator and 
allowed to incubate for 8 hours. More media was then added to the wells until it 
covered the tissue by a 3-4 millimeters and the samples were allowed to incubate 
for another 24 hours in the incubator.  
     One laminin, one fibronectin, and one control sample was put in a new six well 
plate, rinsed twice with 1XDPBS, and fixed with 4% PFA for immunohistochemistry 
(IHC) and H&E staining. The other samples were analyzed with Live/Dead described 
in section 1.3.5 below.  
1.3.5 Live/Dead Assay  
     Live/Dead assay is used to evaluate the viability or toxicity of cells. Calcein AM 
stains viable cells by fluorescing when uptaken and multiplied by esterase activity in 
the cytosol. EthD-1 fluoresces in dead cells because it is only able to penetrate the 
membranes in cells where the membrane is compromised and then stains the 
nucleic acids. 4mM Calcein AM and 2mM Ethidium homodimer-1 (EthD-1) from 
Molecular Probes were used. 6 ul of the EthD-1 was added to 3 mL 1XDPBS in a 
conical and vortexed. 1.5 ul of Calcein AM was added the conical and the solution 
was vortexed again.  
     The media was removed from the wells and the samples were rinsed with 
prewarmed 1XDPBS. One laminin, one fibronectin, and one control sample was 
placed in a new well plate with 1 mL of the prepared Live/Dead solution on each 
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sample. The well plate was then covered in foil to protect from light and put in the 
37oC incubator for 20 minutes. The samples were placed on a glass slide (cell seeded 
side down) and viewed on a fluorescent microscope with a red filter to see any dead 
cells and a green filter to show the live cells.  
1.3.6 Immunohistochemistry for Analysis of Laminin Presence  
     This immunohistochemistry (IHC) protocol was taken from a graduate from the 
lab, James Chow. Samples were sectioned onto glass slides on as described in the 
H&E histology in section 1.1.6. The slides were then deparaffinized in xylene and 
ethanol solutions and then rehydrated to water. For antigen retrieval, the Slides 
were put in 10 mM citric acid monohydrate pH balanced to 6.0 in a microwavable 
slide rack and coplin jar. The slides were microwaved on half power for 5 minutes 
and then the temperature was checked to see if it had reached 90-100oC and more 
citric acid solution was added if any had boiled over. The samples were microwaved 
for an additional 20 minutes, checking the temperature and refilling the coplin jar 
with citric acid solution if needed. The slides were then allowed to cool at room 
temperature for 1 – 2 hours. The samples were then rinsed in tris buffer saline 
(TBS) pH balanced to 7.5 twice for 5 minutes each rinse. A Kim wipe was then used 
to wipe excess buffer from the slides and a wax pen (Vector Immedge Pen) was used 
to individually circle the tissue sections on the slides. The wax was allowed to dry 
for 2-3 minutes before putting back in the TBS.  For tissue permeabilization, the 
slides were rinsed twice in 0.025% triton for 5 minutes each rinse and then rinsed 
once in TBS for 5 minutes. To block non-specific binding, the sections were 
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incubated in 1.5% normal blocking serum (horse normal serum in TBS from 
Vectastain Kit) for 45 minutes. The normal blocking serum was wicked well from 
the slides and then the primary antibody [anti-laminin from Abcam, ab 11575, at a 
concentration of 4ug/mL in TNB buffer (1mL blocking reagent solution from 
Vector’s Western Blot kit in 19 mL TBS)] was added to the positive sections and TBS 
was applied to the negative control sections. The primary antibody was incubated 
on the samples overnight at 4oC in a self-made humidity chamber (slides were 
placed over wet paper towels in a glass Pyrex dish and covered with cling wrap. 
Following incubation, the slides were rinsed twice in TBS for 5 minutes each rinse. 
To block the endogenous peroxidase, the slides were incubated in a solution of 0.3% 
H2O2 and 0.3% normal horse serum in TBS for 30 minutes. The slides were then 
rinsed in TBS for 5 minutes prior to applying the secondary biotinylated antibody 
(30 ul normal horse blocking serum and 10 ul anti-rabbit in 2 mL TBS) for 30 
minutes at room temperature. The slides were once again rinsed with TBS for 5 
minutes and then incubated in ready to use Avidin-Biotin Complex (ABC) for 30 
minutes at room temperature followed by rinsing twice in TBS for 5 minutes. The 
antibody was carefully observed while developed with DAB substrate solution (5 
mL water, 2 drops Buffer Stock Solution, 4 drops DAB solution from Vector, and 2 
drops H2O2). The samples were carefully observed under a light microscope for a 
brownish color to appear signifying the antibody has been developed. Once the 
brown tint is observed, the reaction was immediately quenched with distilled water 
(the anti-laminin took a full 5 minutes to develop). All slides were rinsed in tap 
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water 5 minutes and counter stained in diluted hematoxylin (50% hematoxylin and 
50% water) for 45 seconds, rinsed in water, dehydrated in xylene and ethanol 
solutions, cleared with clearing agent, and cover-slipped with mounting medium. 
The slides were imaged under a light microscope.  
1.4 Study 4: Static seeding of bovine pericardium tissue samples with 
endothelial cells treated with fibronectin and laminin protein substrates 
and PureCol, Q.Gel, and Fibrin Glue hydrogels for increased cellular 
adhesion 
     Since endothelial cell-to-cell communication and spreading out is an imperative 
part of the cells’ functioning, study 4 aimed to increase cell attachment by providing 
an even surface that more closely mimics the in vivo extra-cellular matrix and 
basement membrane where native endothelial cells reside.   
1.4.1 Sample Preparation and Experimental Design 
     Decelled, PGG fixed (0.075% PGG) bovine pericardium was prepared as described 
in previous methods. 3 different hydrogels – Q.Gel, PureCol, and fibrin glue – were 
prepared and applied to 12 mm pericardium punches in a 24 well plate as detailed 
in the following sections. Each combination of gel and substrate was repeated for 
analysis at 2 time points: 3 day and 7 day. 
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Figure 26: Experimental layout of combination of the 3 gels, 2 substrate solutions, and 
controls in a 24 well plate. 
1.4.2 Scaffold Modification with Fibrin Glue 
     This protocol was adapted from an article by the Hoerstrup lab published in 
Biomaterials.44 When fibrinogen (human from Sigma) and thrombin (65% clottable 
protein from human plasma from Sigma) are mixed at 37oC an enzymatic reaction 
occurs and an irreversible gel forms. 20 mg/mL fibrinogen was prepared by 
dissolving 40 mg fibrinogen in 1 mL 1XDPBS and sterile filtering the solution into a 
sterile conical and putting the solution on ice. 12.5 units/mL of thrombin was made 
by dissolving 250 ul of sterile filtered Dulbecco’s Modified Eagle Media (DMEM) pH 
balanced to 6.3 in 25 unit thrombin (comes sterile in glass jar with rubber lid). The 
thrombin was then diluted to 12.5 units/mL by adding 750 ul of sterile filtered 2mM 
CaCl solution [222 mg CaCl in 100 mL HEPES buffered saline (HBS)] and put in ice. 
Immediately before putting the gel on the tissue, 150 ul of the thrombin solution was 
thoroughly mixed in 150 ul of the fibrinogen solution and quickly pipetted 50 ul 
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directly onto the respective pericardium samples. The samples were also incubated 
at 37oC for 1.5 hours. Excess gel, not on the tissue, was aspirated and the samples 
were rinsed twice with sterile 1XDPBS.  
1.4.3 Scaffold Modification with PureCol  
     PureCol is 0.5% pure bovine type 1 collagen in DMEM/F-12 media and forms a 
gel when warmed to 37oC.  Prepared PureCol solution (3.1mg/mL bovine type 1 
collagen from Advanced Biomatrix) was diluted to 50 ug/mL in 1 mL of sterile 
filtered 0.01 M HCl solution in ddH2O. 100 ul of the gel solution was added to the 
respective 12 mm punches of pericardium in the 24 well plate and allowed to 
incubate at 37oC for 1.5 hours. After incubation, any gel that had run off of the tissue 
was aspirated and the samples were rinsed twice in sterile 1XDPBS.  
1.4.4 Scaffold Modification with Q.Gel 
     Q.Gel is a synthetic extracellular matrix that forms a gel when warmed to 37oC. 
500 ul of gel was made by adding 400 ul of Buffer A (3D Matrix #2101) to the vial 
Q.Gel powder (3D Matrix #1001) prewarmed to room temperature and vortexing 
for 2 seconds. The buffer and the power come in sterile one time use containers, so 
there was no sterile filtering of this solution. 50 ul of the prepared gel was then 
pipetted on the respective tissue samples and incubated at 37oC for 1.5 hours. Any 
remaining gel on the bottom of the well was aspirated and the samples were rinsed 
twice with sterile 1XDPBS.  
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Figure 27: Q.Gel provides an environment that closely mimics the native environment for cells 
by providing physical and soluble signals.45 
1.4.5 Scaffold Modification with Substrates and Cell Seeding 
     The respective samples were then incubated in 500 ul of 5 ug/mL laminin, 5 
ug/mL fibronectin, or 1XDPBS for control for 24 hours as detailed in section 1.3.2. 
1x105 hCAECs suspended in 200 ul of endothelial culture media was drop seeded on 
the samples in each well as detailed in section 1.3.4. 500 ul of culture media was 
added to completely cover the samples 4 hours later.  
1.4.6 Cellular Adhesion, Coverage, and Viability Analysis  
     After 3 days of incubation, one of each sample (12 samples total) was rinsed with 
1XDPBS and cut in half. The media was changed on the remaining 12 samples 
reserved for analysis on day 7 of incubation. Of the samples cut in half, half was 
fixed in 10% phosphate buffered formalin for H&E and the other half was put in 
prepared Live/Dead solution. Live/Dead assay was followed as described in section 
1.3.5. The fixed samples were put in processing cassettes after two weeks in 10% 
formalin in 4oC. Since the scaffolds were coated in hydrogels, they are subject to 
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deterioration in the automatic processor due to the harsh vacuuming paraffin 
infiltration steps. Therefore the automatic processor was specially programmed and 
run according to a protocol found in literature for processing and paraffin 
embedding hydrogels opposed to the aforementioned processing protocol.46 
Tissue scaffold with hydrogel surface modification processing protocol: 
(Note: this protocol is only beneficial for the samples with hydrogels on their surface and may overly 
dehydrate unmodified samples.) 
• 10% buffered formalin (1 min) at 37oC
• 10% buffered formalin (1 min) at 37oC
• 70% ethanol (60 min) at 37oC
• 80% ethanol (60 min) at 37oC
• 95% ethanol (60 min) at 37oC
• 100% ethanol (60 min) at 37oC
• 100% ethanol (60 min) at 37oC
• 100% ethanol (60 min) at 37oC
• Xylene (60 min) at 37oC
• Xylene (60 min) at 37oC
• Paraffin (15 min) at 58oC
• Paraffin (15 min) at 58oC
• Paraffin (15 min) at 58oC
Paraffin embedding, sectioning, staining, and imaging was following as described in 
section 1.1.6. The Live/Dead and histology steps were repeated for the 7 day time 
point samples as well.  
1.5 Study 5: Application of fibrin glue hydrogel and protein substrate surface 
modifications on decelled and harvested porcine native valves, dynamic 
seeding, and cellular adhesion and uniform coverage analysis  
     After finding positive results in study 4 for endothelial cell attachment and 
spreading on the fibrin glue and protein substrate combination samples compared 
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to the Q.Gel, the PureCol, or the controls, this study attempted to apply this surface 
modification method to a valve. Another aim of this study was to determine if there 
is a conclusive preference for laminin or fibronectin.  
1.5.1 Aortic Valve Harvesting and Decellularization by Immersion 
     Porcine hearts were donated from Snow Creek Meat Processing Facility in Seneca, 
SC. The hearts were put in ddH2O over ice while dissection bins and tools were set 
up. The aortic valve was carefully harvested above the valve up to the sino-tubular 
junction, leaving a 5 – 1- mm of length on the two coronary arteries, and ensuring to 
retain a thin layer of septum muscle and membranous septum on the ventricular 
side of the valve. The retained muscle layer and membrane at the ventricular side of 
the valve was termed the “skirt”. The figures below show the portion that was 
dissected in relation to the heart anatomy and the resultant valve.  
Figure 28: The image on the left highlights the area of the aortic valve that was harvested. The 
middle image is the harvested valve showing the “skirt” at the bottom and aortic root at the 
top. The image on the right is the view from the ventricular side showing the “skirt”. 
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     The harvested valves were then decellularized following an established protocol 
previously developed in the lab by Lee Sierad. All washes and incubations were 
conducted on a shaker plate. First, the valves were subjected to a series of hypotonic 
ddH2O washes. Native porcine cellular components and fragments were removed in 
a 0.05 M NaOH wash followed by a two day incubation in a decell solution consisting 
of a collection of detergents (50mM Tris, 0.25% SDS, 0.5% DOC, 0.5% Triton x100, 
0.2% EDTA in ddH2O and pH balanced to 7.4±0.05). The decell solution was then 
rinsed from the valves by undergoing a series of rinses and washes in ddH2O 
changes, incubated in 0.02% sodium azide for 20 hours, rinsed in ddH2O changes, 
washed in 70% ethanol changes, rinsed in ddH2O changes, incubated in 0.02% 
sodium azide for 20 hours, and then incubated in 1XDPBS changes. The valves were 
then removed of DNA and RNA components by incubating for 2 days in 2 changes of 
prewarmed DNase/RNase solution at 37oC. The valves were then rinsed of the 
DNase/RNase solution and the removed nuclear components through a series of 
1XDPBS rinses and incubation in 0.02% sodium azide for 24 hours. All following 
steps were conducted sterilely by using aseptic technique, sterile tools and bottles, 
and sterile filtered solutions. The valves were sterilized in a 2 hour incubation in 
0.1% peracetic acid and then rinsed and incubated in a series of changes of 1XDPBS 
for 24 hours.  
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1.5.2 Harvested Valve PGG Fixation and Neutralization 
     In order to prevent leaflet folding or bunching, the leaflets were stuffed with 
sterile cotton balls soaked in sterile filtered 0.15% PGG solution. The cotton stuffed 
valves were put in a jar filled with 0.15% PGG solution, the jar was covered in foil to 
protect from light, and the valves were incubated in the solution for 21 hours on a 
shake plate. Following the PGG incubation, the cotton was removed and the valves 
were washed and incubated in sterile 1XDPBS changes for 24 hours. The PGG was 
neutralized by incubating the valves in 50:50 DMEM/FBS plus 1% PSA on the shake 
plate overnight.  
1.5.3 Harvested Valve Surface Modification with Fibrin Glue and Substrates 
     The valves were prepared to fit in the seeding chamber by inserting them in 
mounting rings designed by Lee Sierad. This preparation was done prior to surface 
medication treatment so the surface treatment would not be disrupted afterward. 
To mount the valves, the “skirt” was crushed between two 3D printed rings. To fully 
crush the tissue between the rings and hold the skirt securely in place, the 3D 
printed rings with the crushed tissue were placed between to larger metal rings 
with a heavy duty spring and metal rings were threaded together. For cell seeding it 
is desired to have the cusps and inside of the valve completely closed off so a small 
concentrated volume of cell solution can be retained in the area of interest. In order 
to create this seal, the coronary arteries were sutured shut.  
     The valves are now ready for surface modifications. The fibrin glue was prepared 
as detailed in section 1.4.2. In order for the gel to form on the tissue only and not 
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immediately upon mixing the thrombin with the fibrinogen, the thrombin and 
fibrinogen mixture was made at a ratio of 1:5 thrombin to fibrinogen to reduce 
gelation time and the mixture was kept on ice. Using a paintbrush for even coverage 
of gel on the tissue, the gel was spread on the prewarmed valves so the fibrin would 
gel when in contact with the tissue. The paintbrush was dipped in ice water between 
applications so a clump of gel would not form on the brush. The gel was applied on 
both sides of the cusps, and the sinuses in 3 applications allowing 3 – 5 minutes 
between applications for the gel to preset. The valves were put back in the oven at 
40oC for 1.5 hours to allow the gel to fully polymerize.  
     After gel polymerization, 2 of the valves were incubated in 5ug/mL of laminin 
solution and the other 2 valves were incubated in 5ug/mL of fibronectin solution for 
48 hours at 37oC (solutions prepared as described in section 1.3.2). To completely 
seal the interior of the valve, a clear silicone membrane was sutured to the bottom 
of the aortic root (this step was not be performed when the valve was mounted in 
the rings and the coronaries were sutured because it blocks access to the ventricular 
side of the leaflets which was necessary when painting on the fibrin glue). The 
culmination of these preparations and modifications to the valves are shown in the 
figure below. 
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Figure 29: Harvested aortic valve mounted in rings, coronary arteries sutured, and silicone 
membrane sutured to seal off the aortic side of the valve. 
1.5.4 Endothelial Cell Seeding of Harvested Valve in Dynamic Seeder 
     The prepared and mounted valve was placed in an acrylic seeding chamber. The 
mounting rings were specially designed to fit snuggly and rest on a lip at the top of 
the seeding chamber so the valve is secured in place with the aortic root protruding 
into the center of the chamber and the ventricular side of the valve facing upwards. 
After the valve was put in place in the chamber, 23x106 of passage 8 hCAECs were 
suspended in 40 mL of culture media and 10 mL of the cell suspension was pipetted 
into each of the valves. The suspension was carefully observed to ensure it was 
staying in the interior of the valve and not leaking into the bottom of the chamber. 
Additional culture media was used to fill the valve until the media reached the top of 
the cusps.  To create a tight seal between the lid and the chamber, an O-ring was 
placed around 3D printed lids (Designed by Lee Sierad) and pressed into the acrylic 
chamber. For sterile media exchange, 2 claves (show in blue in Figure 31) were 
attached to the ports extending from the lid via luer-loc mechanism. To fill the small 
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remaining volume between the lid and the top of the valve, a syringe filled with 
culture media was attached to one of the claves and a male luer was attached to the 
other to allow air to exit as the chamber is filled with media. The media was injected 
into the chamber via the syringe until excess media came out of the adjacent open 
clave.  
Figure 30: Seeding chamber with ring mounted valve inside and the 3D printed lid attached 
and claves (blue) attached for media exchange. 
Figure 31: View from the bottom of the seeder of the sealed off valve filled with cell solution. 
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     In order to achieve uniform cell coverage on the all surfaces of the valve which 
has an intricate anatomy, a device was used that continuously rotates the chamber. 
This device was developed by a previous student in the lab, Richard Pascal, and was 
termed “the rotator”. The rotator consists of a metal frame that connects to a 
stepper motor. The rotator was wired to a data acquisition system (DAQ) that is 
controlled by LabVIEW so it can be programmed to rotate at a set rotations per 
minute value (rpm) and for set increments of time. The rotator secures into a shake 
plate, but note the shake plate was not turned on for these studies. After the valves 
were filled with the cell solution, the chambers were secured in the rotator’s metal 
frame and set to rotate axially with respect to the lumen of the valve according the 
following protocol in Table 1 below at 37oC. To ensure each cusp has adequate 
chance of having cells attach, the rotating protocol was set to allow each of the 3 
cusps to incubate on the bottom side of the chamber during the static steps. Steps 3 
– 7 were repeated for an additional 8 hours. At this time, the chambers were taken
out of the rotator, the media was changed on the valves, and they were then placed 
in the incubator with the lids down to prevent media from leaking through the 
silicone membrane on the aortic side. The valves incubated in this position for 2 
days.  
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Table 1: Series of rotations and static incubations for uniform endothelial cell coverage 
Figure 32: Rotator system consists of the metal frame where the seeding chambers can be 
secured and is connected to a stepper motor that is controlled by LabView. The system resides 
in the 37C incubator for cell viability. 
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Figure 33: The metal frame of the rotator is secured to a shake plate. There are 2 different 
attachments for the chambers to connet in to depending on the desired rotation orientation 
(axially or end-over-end).  Both attachements are shown. 
1.5.5 Cellular Adhesion, Coverage, and Viability Analysis 
     After the 2 day static incubation, the valves were removed from the chambers and 
each of the cups as well samples from the sinuses were dissected from the valves. 
One cusp from the fibronectin samples and one cusp from the laminin samples were 
imaged with Live/Dead (section 1.3.5) to analyze cell viability and cell spreading. 
One set of fibronectin and laminin cusps was fixed in Karnovsky’s fixative for 
scanning electron microscopy to see the cell morphology (described in section 1.5.6 
below). One set was fixed in 4% PFA and then imaged with DAPI to see the 
distribution of nuclei (section 1.1.5). Another set was fixed in 4% PFA for H&E 
staining to analyze the distribution of the cells across the scaffold surface using the 
modified processing protocol for hydrogels (section 1.4.6). IHC was also done to 
analyze the functioning and expression of the endothelial cells (section 1.3.6). 
     For IHC, the sections were stained for endothelial cell marks CD31 (cluster of 
differentiation 31), vWF (von Willebrand Factor), and VE-cadherin (vascular 
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endothelial cadherin). The previously described IHC protocol was used. Anti-CD31 
(rabbit) was used at a concentration of 1:50, anti-vWF was used at 4 ug/mL (rabbit), 
and VE-cadherin (rabbit) was used at a concentration of 1:50.  
1.5.6 Statistical Analysis of Fibronectin and Laminin Treatments Using 
ImageJ 
     Using the cusps stained with DAPI, both the inflow and the outflow sides of the 
cusps (1 from each of the 4 valves) were fluorescently imaged from corner to 
corner, ensuring cells were not included in duplicate frames. The number of images 
taken totaled to 272. The images were then imported into ImageJ software. In 
ImageJ the images were converted to 8-bit to increase the contrast between the 
fluorescing cells and the background. The threshold was then adjusted until the 
program highlighted each individual cell as accurately as possible. The 8-bit 
conversion and threshold settings were then applied to every image and the 
“analyze particles” function was used to count the number of cells were detected in 
each image and record the data in a spreadsheet. A student’s t-test (α=0.05) was 
used to analyze the differences between the sides and treatments of the cusps.  
1.5.7 Scanning Electron Microscopy Sample Preparation and Imaging 
     Scanning electron microscopy was used to image the surface morphology.  
Following the removal of the seeded valves from the chambers, one cusp from the 
fibronectin sample and one cusp from the laminin sample were carefully cut away 
from the valve and stored in Karnovsky’s fixative (2.5% gluteraldehyde, 2% 
formaldehyde in 0.1 cacodylate, pH=7.4).  Prior to SEM analysis samples were 
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dehydrated in a series of ethanol dilutions.  This was followed up by a critical point 
drying step using Hexamethyldisilazane (HMDS).  Once fully dehydrated, samples 
were mounted, platinum sputter coated in a Hummer 6.2 Sputter Coater shown in 
Figure 29 at the Clemson AMRL facility and imaged using the Hitachi S-4800 
microscope.  
Figure 34: Anatech USA Hummer 6.2 Sputter Coater 
1.6 Study 6: Application of fibrin glue hydrogel and laminin substrate 
solution surface modifications on decelled and harvested porcine native 
valves, dynamic seeding, and in vitro testing for cellular retention 
analysis 
     After concluding that the combination of laminin and fibrin glue resulted in the 
best cell attachment in study 5, this final study was conducted to analyze the surface 
modification method for cellular retention by exposing an endothelialized valve to 
physiological shear stress in the bioreactor.  
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1.6.1 Valve Preparation, Surface Modification, and Endothelial Seeding 
     Valves were harvested, decellularized, fixed in 0.15% PGG, neutralized, crushed 
into a mounting ring, coated with fibrin glue, and incubated in 5ug/mL of laminin 
solution as detailed in study 5. The valve was seeded in the rotator with 5.5x106 
passage 4 human aortic endothelial cells (hAECs) and rotated according to the 
protocol in Table 2. Steps 9 – 10 were repeated for 24 hours.  
Table 2: Rotating protocol for endothelial seeding in study 6 
1.6.2 In Vitro Testing in the Heart Valve Bioreactor 
    After the valve was removed from the seeder, it was placed in the heart valve 
bioreactor design previously described. The flow rate and pressures were gradually 
increased over 5 days to reach physiological pressures. The ramp up protocol is 
described in Table 3.  
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Table 3: Ramp up protocol over 5 days for seeded valve in the bioreactor 
1.6.3 Cellular Adhesion, Coverage, and Viability Analysis 
     After reaching physiological pressure for 10 minutes, the valve was removed 
from the bioreactor and the cusps were dissected. One cusp was fixed in 4% PFA 
and then stained and imaged with DAPI. Another cusp was stained and imaged with 
Live/Dead. The last cusp was reserved for cryo-sectioning and H&E staining since 
cryo-sectioning is gentler on tissues and is more likely to preserve the hydrogel. 
This sample was fixed in 4% PFA for 3 hours, incubated in 15% sucrose solution in 
1XDPBS and then a 30% sucrose solution to prevent ice artifact formation in the 
samples when they are frozen. The sample was then gradually infiltrated with cyro-
section freezing medium (OCT) by soaking in 1XDPBS, 50:50 1XDPBS/OCT, and 
finally 100% OCT. The infiltrated sample was then frozen at -20oC in a cryo-block 
embedded in OCT. The embedded cusp was sectioned in 10 um sections using a 
cyro-section microtome and placed directly on a glass side. The slides were put in 
freezer  (-20oC) before staining with H&E following a shortened staining protocol. 
After staining the slides were coverslipped and imaged using a light microscope. 
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2 Chapter 2: Experimental Results and Discussion 
2.1 Study 1:   Static seeding of TE valve with incremental rotation in seeder 
for analysis of cellular adhesion 
     The results of study 1 showed that sufficient cellular coverage can be achieved on 
a tissue-engineered valve made of PGG fixed bovine pericardium and seeded with 
human adipose derived stem cells. From the DAPI images shown in Figure 30, cells 
were able to attach to the pericardium and create complete coverage on the surface. 
From the H&E stained cross sections in Figure 31, a monolayer of cells can be seen 
on the scaffold’s surface. The H&E sections, taken at 3 different locations of the cusp, 
also shows cell attachment was present along the entire surface of the cusp. These 
images do reveal, however, cell attachment was greater at the center of the cusp 
compared the outer edge/corner of the cusp. The DAPI images and H&E images 
were taken from 2 different cusps which additionally implies all three of the cusps 
were adequately covered with cells. It was a concern that cells would prefer and 
settle on the surfaces at the bottom of the seeder which is why the valve was rotated 
every 6 hours along with the addition of new cells. Altering the position of the valve 
seemed to allow a more uniform cellular distribution. No empty spots were found 
on the valve cusps.  
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Figure 35: Nuclear distribution on the inflow (left) and outflow (right) surfaces of TE valve 
statically seeded and stained with DAPI. Taken at 10x (top) and 2.5x (bottom). 
Figure 36: H&E stain showing seeded HADSCs on the surface of TE valve cusp cross sections 
taken from the center of the leaflet (A), one-third of the way through the leaflet (B), and the 
outer edge of the leaflet (C). 
Inflow 
A B C 
Outflow 
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2.2 Study 2: Static seeding of TE valve with incremental rotation and 
exposure to shear stress for analysis of cellular retention 
     Compared to study 1, half concentration of PGG was used in study 2 to increase 
the pliability of the pericardium. The pericardium fixed in 0.15% PGG in the first 
study was very thick and difficult to suture into the mount. Since PGG is a cross-
linker, decreasing the concentration, decreases the rigidity of the tissue. The seeding 
method was repeated with an even higher concentration of cells, so it is assumed 
there was a sufficient layer of cells on the valve’s surface prior to putting the valve in 
the bioreactor. However after the valve was put in the bioreactor and exposed to 
very low pressures (12mmgHg/4mmHg) and low stroke volume (1.43 mL), the cells 
were no longer able to remain attached to the pericardium’s surface. Figure 32 
shows the pericardium surface after removal from the bioreactor and imaged with 
DAPI. Almost no cells can be seen. The shear stress was too great for the HADSCs 
statically incubated on pericardium for 24 hours. It is thus implied the cells were not 
adequately attached to the surface prior to in vitro testing. Inadequate cellular 
adhesion and retention could be attributed to the fact the cells used were not 
differentiated endothelial cells. Native endothelial cells create a strong network and 
communicate with each other and the underlying cells and their surrounding 
environment. In vivo, endothelial cells produce and reside in a rich layer of extra-
cellular matrix which provides mechanical support and attachment sites. The 
endothelial cell’s relationship with its surroundings could be associated with the 
cell’s ability to adhere to the basal lamina. Without the presence of this extracellular 
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matrix and the differentiated endothelial cells, it is possible the cells were not able 
to establish adequate attachment to the pericardium. 
Figure 37: Nuclei distribution on the surface of inflow (left) and outflow (right) sides of a cusp 
taken from seeded TE valve after in vitro testing and stained with DAPI. Taken at 2.5x. 
2.3 Study 3: Static seeding of bovine pericardium tissue samples with 
endothelial cells and with added adhesive protein substrates for 
increased cellular adhesion 
      After finding insufficient cellular attachment and retention in study 2 using 
HADSCs seeded on pericardium, this study used known endothelial cells drop 
seeded on pericardium incubated in adhesive protein solutions, fibronectin and 
laminin. These protein substrates are found in native extra-cellular matrix and 
provide as attachment sites for endothelial cells to the basal lamina. Fetal bovine 
serum (FBS) was used as a control, as this is a component added in normal culture 
media so all samples were exposed to FBS after cells were seeded and media was 
added. In the Calcein AM fluorescently labeled images in Figure 33, the 2.5x images 
show in conclusive results, as all sample appeared to have adequate coverage. In the 
10x images, it is seen that the cells seeded on the pericardium treated with laminin 
(A), display more spreading out compared to the other samples. Cell spreading out 
1000 µm 1000 µm
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is a sign the cells are interacting with the environment and neighboring cells rather 
than staying in a spherical balls.  
     The cross sections analyzed with H&E, does not show conclusive results as very 
few cells (nuclei are stained dark purple), appear in any of the samples. This could 
be attributed to the presence of only a few number of cells therefore when 0.05 um 
cross sections were taken, not many cells were captured in the sections. Some cells 
could have also been removed in the tissue processor which is rough on samples as 
it infiltrates them with paraffin. The surface of the pericardium is very uneven as 
seen in Figure 34. The pericardium scaffold has a “cotton-candy” topography which 
may have prevented adequate attachment and creation of the endothelial cell 
network amongst the neighboring cells.  
     IHC was also done to determine the presence of the adhesive protein substrates 
after culturing cells on the treated scaffolds. The immunohistchemical staining with 
anti-laminin on both the control sample (FBS) and the laminin treated sample 
revealed positive stain for laminin presence in both samples. The staining showed 
laminin was present within the samples, and slightly present on the surface, 
meaning either the laminin solution was able to travel within the pericardium or 
laminin existed within the scaffold even prior to treatment.  
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Figure 38: Calcein AM stained pericardium scaffolds treated with laminin (A), fibronectin (B), 
and FBS for control (C) showing endothelial cell distribution and spreading out on the surface. 
Top row imaged at 2.5x and the bottom row at 10x.  
Figure 39: Cell distribution on cross sections of pericardium scaffolds treated with laminin 
(A), fibronectin (B), and control sample incubated in FBS (C) and seeded with endothelial cells 












Figure 40: staining with anti-laminin showing the presence of laminin in cross sections of 
scaffolds treated with laminin and FBS for control.  (A) FBS negative control, (B) FBS sample 





Figure 41: IHC staining with anti-laminin on laminin incubated and seeded scaffolds imaged at 
20x. Both images show cross sections tagged with the antibody. 
2.4 Study 4: Static seeding of bovine pericardium tissue samples with 
endothelial cells treated with fibronectin and laminin protein substrates 
and PureCol, Q.Gel, and Fibrin Glue hydrogels for increased cellular 
adhesion 
     This study aimed to increase endothelial cell attachment by providing an 
environment that more closely mimics the in vitro surroundings. While the protein 
substrates were added in the previous study, there still lacks an extra-cellular 
matrix (ECM) or basal lamina to provide binding sites for the endothelial cells to 
attach. 3 different hydrogels were used in this study to mimic the ECM, providing an 
even surface for attachment and communication as well as mechanical support that 
may have been lacking in the previous studies. After a 3 day incubation of the 
surface modified pericardium with drop seeded endothelial cells, it can be seen in 
Figure 37 the cells were attaching and spreading out with the fibrin glue samples, 
the Q.Gel with laminin and without substrate samples, and the scaffold only treated 
with laminin. The histological samples at the 3 day time point were again 
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inconclusive, as it appears the cells were again washed away in the processor or 
during the rinsing steps prior to fixing the tissue.  
      After the 7 day incubation, almost no cells were seen in the Calcein AM tagged 
images and black spots were observed on the scaffolds. These black spots are 
thought to be PGG coming of the tissue, as the tissue in this experiment was not 
neutralized in 50:50 DMEM/FBS prior to seeding on accident. The media was 
changed at the 3 day time point, and as shown in Figure 38 the media on the 
scaffolds was yellow by day 7 indicating an acidic pH likely due to the PGG.  
     The histological cross sections in Figure 41 shows the gel on the surfaces well. 
The fibrin glue formed a straight line across the surface of the pericardium. 
Hematoxylin (dark purple) stains negatively charged compounds, such as DNA or 
RNA. The fibrin glue and the Q.Gel with fibronectin treated sample shows cells on 
the surface that was stained by the hematoxylin. The same thing is seen in the fibrin 
glue and laminin treated sample but not to the same degree. The collagen from the 
PureCol can also be seen on the surface in the cross sections but no cells were 
observed. The scaffolds with the synthetic ECM, Q.Gel, is also seen in the histology. 
The Q.Gel actually appears to have infiltrated the pericardium by about 100 um and 
is stained by the hematoxylin in both the 3 day and 7 day histology samples. The 
samples that were not treated with either of the hydrogels, show no cellular 
attachment in the histology images.    
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Figure 42: Calcein AM stained seeded scaffolds treated with a combination of hydrogels and 
protein substrates showing cellular attachment and spreading after incubating for 3 days. 
Taken at 2.5x. 
Figure 43: 24 well plate with the seeded scaffolds in culture media at day 7 of incubation (3 
































Figure 44: Calcein AM stained seeded scaffolds treated with a combination of hydrogels and 
protein substrates showing cellular attachment and spreading after incubating for 7 days. 
Taken at 10x. 
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Figure 45: Cross sections of paraffin embedded cusps taken from porcine valve surface 
modified with hydrogels and protein substrates and seeded with endothelial cells stained 
with H&E after 3 day incubation. Taken at 10x. 




















Figure 46: Cross sections of paraffin embedded cusps taken from porcine valve surface 
modified with hydrogels and protein substrates and seeded with endothelial cells stained 
with H&E after 7 day incubation. Taken at 10x. 
2.5 Study 5: Application of fibrin glue hydrogel and protein substrate surface 
modifications on decelled and harvested porcine native valves, dynamic 
seeding, and cellular adhesion and uniform coverage analysis 
     Since the previous studies were conducted on sections of tissue samples, the 
purpose of study 5 was twofold: to evaluate the fibrin glue surface modification for 
uniform cell coverage on the surface of heart valve and to conclude if the endothelial 
cells have a preference for the laminin or the fibronectin. Study 5 compares the 
cusps from 4 types of valves – a decelled valve, a native valve, a valve treated with 




















fibrin glue and fibronectin, and a valve treated with fibrin glue and laminin. Figure 
42 shows cross sections of each of these samples stained with DAPI. The native cusp 
is completely infiltrated with cells both on the surface, endothelial cells, and within 
the cusp, interstitial cells. The decelled cusp shows no cells. The cusps treated with 
fibrin glue and laminin shows a few endothelial cells on the surface as well as the 
cusps treated with fibrin glue and fibronectin.  
     The surfaces of the treated cusps were also stained with DAPI. The fibrin glue gel 
allowed the cells to reside in different planes which made it difficult to capture an 
image showing the all of the cells on the surface in one image. Figure 43 shows these 
images. It was also observed that the outflow sides of the cusps had more cells than 
the inflow sides of the cusps. This is probably due to the increased incubation time 
where the valves sat statically with the outflow side up. Overall, greater cellular 
attachment was observed on the valves treated with fibrin glue and laminin 
compared to the valves treated with fibrin glue and laminin. Calcein AM reveals that 
the cells were viable after both treatments, although most cells were observed on 
the inflow side of the laminin sample. An image was taken on the stereomicroscope 
with Calcein AM stain to get a better representative image of the distribution of cells 
on the surface, since this microscope images the surface in 3-dimensions. The image 
from the cusp modified with fibrin glue and laminin in Figure 47 shows a uniform 
cell distribution.  
     Scanning electron microscopic images of the outflow sides of the valves, showed 
more cells on the cusp treated with fibrin glue and laminin compared to the one 
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treated with fibronectin. Both samples however, showed cell spreading meaning the 
cells were interacting well with the environment.  
     IHC analysis revealed a positive stain for von Willebrand factor on the surface of 
both the fibronectin and the laminin treated cusps. VE-cadherin also stained 
positive on the fibronectin treated sample and only slightly positive on the laminin 
treated sample. Anti-CD31 did not show very positive results in either sample, but it 
also was very weak in the native cusp meaning the antibody used may not have 
worked or the antigen retrieval step did not adequately expose the CD31 markers. 
As expected the decelled cusp did not stain positive for any of the endothelial cell 
markers. The presence of these markers, demonstrates the presence and proper 
expression of endothelial cells on the surfaces of the cusps after being modified with 
fibrin glue, protein substrates, and seeded with endothelial cells in a rotating device. 
     Statistical analysis between the 2 valves treated with fibrin glue and fibronectin 
and the 2 valves treated with fibrin glue and laminin showed that more cells were 
found on the inflow sides of the cusps compared to the outflow sides of the cusps in 
all samples. Additionally there was statistical significance between the different 
treatments as well. Many more cells were found on the cusps treated with laminin 
compared to the cusps treated with fibronectin. This is believed to be attributed to 
the fact that laminin is a major component of the basement membrane that serves to 
organize the intricate network of the basement membrane. Therefore laminin may 
attach the endothelial cells better. While fibronectin is only an adhesive protein 
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substrate that is associated with the basal lamina but is not necessarily a part of the 
basal lamia.  
Figure 47: Cross sections of a cusps stained with DAPI taken from:  (A) seeded valve treated 
with fibronectin, (B) seeded valve treated with laminin, (C) native porcine valve, (D) 






Figure 48: Surfaces of cusps taken from seeded valves treated with fibronectin outflow side 
(A) and inflow side (B) and treated with laminin outflow side (C) and inflow side (D). 
Figure 49: Surface morphology of outflow surface of cusps taken from endothelialzed valves 
modified with laminin (left) and fibronectin (right) imaged with SEM. 
100 µm







Figure 50: Decelled valve, native valve, and endothelial seeded valves treated with fibronectin 
and laminin were stained for endoethial cell markers CD31, VE-cadherin, and vWF using IHC. 
Images taken at 10x. 































Figure 51: Calcein AM stain showing living cells on the surface of a cusp taken from a valve 
treated with fibrin glue and protein substrates, laminin (A,B) and fibronectin (C, D), and 
seeded with endothelial cells. A, C show the inflow side and B, D show the outflow side. Taken 
at 10x. 
  
Figure 52: 3D image of calcein AM stain of cusp treated with fibrin glue and adhesive 







Figure 53: Analytics conducted with ImageJ on 272 total DAPI images of the inflow and 
outflow cusp surfaces from 2 valves treated with fibronectin (FN) and 2 valves treated with 
laminin (LM)  
2.6 Study 6: Application of fibrin glue hydrogel and laminin substrate 
solution surface modifications on decelled and harvested porcine native 
valves, dynamic seeding, and in vitro testing for cellular retention 
analysis 
     This study tested a valve treated and seeded identically as in study 4 with fibrin 
glue and laminin in vitro in the bioreactor. The pressure were incrementally 
increased on the valve over a period of 5 days until the systolic pressure reached 20 
mmHg, a physiological pressure. An accumulation of fibrin glue was found in one of 
the cusps and the adjacent sinus after removal from the bioreactor. This cusp was 
stained with DAPI. DAPI showed some cellular retention after implantation in the 
bioreactor. Another cusp was imaged with Calcein AM, but no cells were seen (data 
not shown). The bioreactor however is not a very consistent in vitro test as the 
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pressure is increased by manually opening the gas release and observing the change 
in pressure on the output in LabVIEW. It is believed the cells may not have had 
adequate time to fully attach and be conditioned on the surface before in vitro 
testing. The objective is for the cells to eventually degrade the fibrin glue as they 
release plasminogen and then lay down their own extra-cellular matrix during 
dynamic conditioning in the rotator. When the cells have had time to achieve a 
uniform layer of ECM to reside and communicate effectively, then they can be tested 





Figure 54: DAPI stain showing the presence of nuclei on valve cusps after surface 
modifications with fibrin glue and laminin, seeded with endothelial cells, and exposed to 
physiological shear stress in the bioreactor. Left images are from the outflow side and right 





Figure 55: Porcine valve seeded treated with fibrin glue and laminin and seeded with 
endothelial cells after removal from the bioreactor. One of the coronary sinuses and cusps has 
accumulated a thickened portion of fibrin glue. 
3  
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4 Chapter 3: Conclusions  
4.1 Study 1: Static seeding of TE valve with HADSCS and incremental rotation 
for analysis of cellular adhesion 
• Uniform cellular coverage was achieved statically seeding HADSCs on a tissue-
engineered valve made of PGG fixed bovine pericardium after 4 rounds of 
introducing cells to the suspension and altering the position of the valve.  
4.2 Study 2: Static seeding of TE valve with HADSCS and incremental rotation 
followed by exposure to shear stress for analysis of cellular retention 
• Cells are not retained after exposing the pericardium valve seeded with HADSCs 
and incubated for 24 hours to small shear stresses.  
• Adequate cellular attachment was not achieved prior to putting the valve in the 
bioreactor.  
4.3 Study 3: Static seeding of pericardium samples with HCAECS and treated 
with adhesive protein substrates for increased cellular adhesion 
• Laminin increased endothelial cell spreading on PGG fixed samples of 
pericardium after 24 hours more than pericardium samples incubated in 
fibronectin or fetal bovine serum.  
• Endothelial cell uniformity appears and density appears to be the same between 
the pericardium samples treated with fibronectin, laminin, and FBS.  
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4.4 Study 4: Static seeding of tissue samples with HCAECS and treated with 
protein substrates and hydrogels for increased cellular adhesion 
• Q.Gel and fibrin glue showed increased cell attachment compared to PureCol and 
no gel.  Fibrin glue appeared to increase cell spreading compared to other gels. 
4.5  Study 5: Dynamic seeding of native valve with HCAECS and treated with 
protein substrates and fibrin glue for cellular adhesion analysis 
• Endothelial cell attachment and coverage was observed on decelled and PGG 
fixed porcine valves treated with fibrin glue and protein substrates and then 
seeded in a rotating device for 24 hours and statically incubated for 2 days.  
• From SEM analysis, endothelial cells were starting to spread out in both the 
fibronectin and laminin treated valves.  
• Immunohistochemistry analysis revealed the cells were expressing von 
Willebrand Factor on the surface of the cusps after undergoing surface 
modifications with fibrin glue, protein substrates, and dynamic seeding.  
• More endothelial cells attached to the valves modified with fibrin glue and 
laminin than the valves modified with fibrin glue and fibronectin.  
4.6 Study 6: Dynamic seeding of native valve with HAECS and treated with 
laminin and fibrin glue followed by in vitro testing for cellular retention 
analysis 
• A small number of endothelial cells dynamically seeded on a decelled, PGG fixed 
porcine valve treated with fibrin glue and laminin for 2 days remained attached 
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after in vitro testing in a heart valve bioreactor for 5 days reaching pressures of 
20 mmHg/13.5 mmHg.  
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Future Work 
• Optimize time of seeding, cell concentration, and adhesive protein concentration.
Longer seeding times should be tried to allow for the cells to fully degrade the
fibrin glue and make their way to the surface of the scaffold. Cell concentrations
should be increased to match concentrations found in literature. Higher
concentrations of laminin should be tried.
• Optimize in vitro testing and bioreactor conditioning regiments. The bioreactor
pressure should be increased at a much slower rate over the period of a few
weeks rather than a few days to allow the cells to become conditioned before
being exposed to mechanical forces larger than they can withstand.
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